<html lang="en" xml:lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta content="text/html; charset=utf-8" http-equiv="Content-Type"/>
<script type="text/javascript">var ncbi_startTime = new Date();</script>
<meta content="" name="paf_template"/>
<meta content="pmc" name="ncbi_db"/><meta content="article" name="ncbi_pdid"/><meta content="" name="ncbi_acc"/><meta content="pccj" name="ncbi_domain"/><meta content="record" name="ncbi_report"/><meta content="fulltext" name="ncbi_type"/><meta content="" name="ncbi_objectid"/><meta content="/articles/PMC181183/" name="ncbi_pcid"/><meta content="pmc" name="ncbi_app"/>
<title>Steps Following Attainment of Remission: Discontinuation of Antidepressant Therapy</title>
<link href="https://www.ncbi.nlm.nih.gov/core/jig/1.14.8/css/jig.min.css" rel="stylesheet"/><script src="https://www.ncbi.nlm.nih.gov/core/jig/1.14.8/js/jig.min.js" type="text/javascript"></script>
<meta content="INDEX,NOFOLLOW,NOARCHIVE" name="robots"/><link href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC181183/" rel="canonical"/><link href="http://purl.org/DC/elements/1.0/" rel="schema.DC"/><meta content="Primary Care Companion to The Journal of Clinical Psychiatry" name="citation_journal_title"/><meta content="Steps Following Attainment of Remission: Discontinuation of Antidepressant Therapy" name="citation_title"/><meta content="Richard C. Shelton" name="citation_authors"/><meta content="2001" name="citation_date"/><meta content="4" name="citation_issue"/><meta content="3" name="citation_volume"/><meta content="168" name="citation_firstpage"/><meta content="/pmc/articles/PMC181183/?report=abstract" name="citation_abstract_html_url"/><meta content="15014601" name="citation_pmid"/><meta content="Steps Following Attainment of Remission: Discontinuation of Antidepressant Therapy" name="DC.Title"/><meta content="Text" name="DC.Type"/><meta content="Physicians Postgraduate Press, Inc." name="DC.Publisher"/><meta content="Richard C. Shelton" name="DC.Contributor"/><meta content="2001" name="DC.Date"/><meta content="en" name="DC.Language"/><meta content="Steps Following Attainment of Remission: Discontinuation of Antidepressant Therapy" property="og:title"/><meta content="article" property="og:type"/><meta content="Depressive disorders require long-term treatment with antidepressants, psychotherapy, or both. The goal of antidepressant therapy is complete remission of symptoms and return to normal daily functioning. Studies have shown that achieving remission and ..." property="og:description"/><meta content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC181183/" property="og:url"/><meta content="PubMed Central (PMC)" property="og:site_name"/><meta content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" property="og:image"/><meta content="summary" name="twitter:card"/><meta content="@ncbi" name="twitter:site"/><link href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/css/3.14.1/pmc.min.css" rel="stylesheet" type="text/css"/><link href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" media="print" rel="stylesheet" type="text/css"/><script src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/js/common.min.js" type="text/javascript">//</script><script src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/js/NcbiTagServer.min.js" type="text/javascript">//</script><meta content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'" name="citationexporter"/><script src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js" type="text/javascript">//</script><link href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" rel="stylesheet" type="text/css"/><script src="https://www.ncbi.nlm.nih.gov/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js" type="text/javascript"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-pccj.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta content="" name="cited_in_systematic_reviews"/><link href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC181183/#s3title/pmc/articles/PMC181183/epub/" rel="alternate" type="application/epub+zip"/><link href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC181183/pdf/i1523-5998-003-04-0168.pdf" rel="alternate" type="application/pdf"/>
<link href="//www.ncbi.nlm.nih.gov/favicon.ico" rel="shortcut icon"/><meta content="CE8C26AAD2C9195100000000036701D6.m_8" name="ncbi_phid"/>
<meta content="origin-when-cross-origin" name="referrer"/><link href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" rel="stylesheet" type="text/css"/><link href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" rel="stylesheet" type="text/css"/><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
<body class="article" id="ui-ncbiexternallink-3"><div id="MathJax_Message" style="display: none;"></div>
<div class="grid">
<div class="col twelve_col nomargin shadow">
<div class="sysmessages">
<noscript>
<p class="nojs">
<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="https://www.ncbi.nlm.nih.gov/guide/browsers/#enablejs" target="_blank" title="Learn how to enable JavaScript">more...</a>
</p>
</noscript>
</div>
<div class="wrap">
<div class="page">
<div class="top">
<div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a accesskey="1" class="ui-ncbimenu-link-first" href="https://www.ncbi.nlm.nih.gov/" id="ncbihome" role="menuitem" title="NCBI Home"><span class="offscreen_noflow">NCBI</span><img alt="NCBI Logo" class="ncbi_logo" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" title="NCBI"/></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a accesskey="3" href="https://www.ncbi.nlm.nih.gov/#maincontent" tabindex="0" title="Skip to the content">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a accesskey="4" href="https://www.ncbi.nlm.nih.gov/#navcontent" tabindex="0" title="Skip to the navigation">Skip to
                        navigation</a></li><li class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" id="resource-menu" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="https://www.ncbi.nlm.nih.gov/static/header_footer_ajax/submenu/#resources" role="menuitem" tabindex="-1">Resources</a></li><li class="topmenu ui-helper-reset ui-ncbimenu-item-first" id="all-howtos-menu" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="https://www.ncbi.nlm.nih.gov/static/header_footer_ajax/submenu/#howto" role="menuitem" tabindex="-1">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a accesskey="0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#accesskeys" tabindex="0" title="About My NCBI Accesskeys">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe scrolling="no" src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC181183%2F%23s3title" style="border:none; height:2.5em; width:40em;"></iframe></div></div>
<div class="header">
<div class="res_logo">
<h1 class="img_logo"><a class="pmc_logo offscreen" href="https://www.ncbi.nlm.nih.gov/pmc/">PMC</a></h1>
<div class="NLMLogo">
<a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
<br/>
<a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
</div>
</div>
<div class="search"><form action="/pmc/" method="get"><div class="search_form"><label class="offscreen_noflow" for="database">Search database</label><select id="database"><optgroup label="Recent"><option class="last" data-ac_dict="pmc-search-autocomplete" selected="selected" value="pmc">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option data-ac_dict="pmc-search-autocomplete" value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option><option value="unigene">UniGene</option></optgroup></select><div class="nowrap"><label accesskey="/" class="offscreen_noflow" for="term">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input aria-autocomplete="list" aria-haspopup="true" autocomplete="off" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" id="term" name="term" role="textbox" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." type="text" value=""/><a class="reset" href="https://www.ncbi.nlm.nih.gov/#" style="visibility: hidden;"><img alt="Clear input" src="https://www.ncbi.nlm.nih.gov/core/jig/1.14.8/img/clear.png"/></a></div></div><button class="button_search nowrap" cmd="go" id="search" type="submit">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
<a href="https://www.ncbi.nlm.nih.gov/pmc/advanced/">Advanced</a>
</li><li>
<a href="https://www.ncbi.nlm.nih.gov/pmc/journals/">Journal list</a>
</li><li class="help">
<a href="https://www.ncbi.nlm.nih.gov/books/NBK3825/" target="_blank">Help</a>
</li></ul></div>
</div>
</div>
<div class="content">
<div class="container">
<div class="content eight_col col" id="maincontent">
<div class="navlink-box">
<ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a class="navlink" href="https://www.ncbi.nlm.nih.gov/pmc/journals/">Journal List</a></li><li class="archive"><a class="navlink" href="https://www.ncbi.nlm.nih.gov/pmc/journals/130/">Prim Care Companion J Clin Psychiatry</a></li><li class="issue-page"><a class="navlink" href="https://www.ncbi.nlm.nih.gov/pmc/issues/5822/">v.3(4); 2001</a></li><li class="accid">PMC181183</li></ul>
</div>
<div class="pmc-page-banner whole_rhythm"><div><img alt="Logo of pccj" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/logo-pccj.gif" usemap="#logo-imagemap"/><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" coords="0,0,499,74" href="http://www.psychiatrist.com/pcc/index.htm" ref="reftype=publisher&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" shape="default" target="pmc_ext" title="Link to Publisher's site"/></map></div> </div>
<div class="">
<div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span role="menubar"><a aria-expanded="false" aria-haspopup="true" href="https://www.ncbi.nlm.nih.gov/#" role="menuitem">Prim Care Companion J Clin Psychiatry</a></span>. 2001; 3(4): 168–174. </span></div><div> </div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC181183</span></div><div class="fm-citation-pmid">PMID: <a href="https://www.ncbi.nlm.nih.gov/pubmed/15014601">15014601</a></div></div></div></div><h1 class="content-title">Steps Following Attainment of Remission: Discontinuation of Antidepressant Therapy</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Shelton%20RC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15014601">Richard C. Shelton</a>, M.D.<sup></sup></div><div class="contrib-group aff-tip" style="display:none"></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a class="pmctoggle" href="https://www.ncbi.nlm.nih.gov/#" rid="idm140192409910640_ai">Author information</a> <a class="pmctoggle" href="https://www.ncbi.nlm.nih.gov/#" rid="idm140192409910640_an">Article notes</a> <a class="pmctoggle" href="https://www.ncbi.nlm.nih.gov/#" rid="idm140192409910640_cpl">Copyright and License information</a> <a href="https://www.ncbi.nlm.nih.gov/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140192409910640_ai" style="display:none"><div class="fm-affl" id="idm140192405811312" lang="en">From the Vanderbilt University Medical Center, Nashville, Tenn.</div><div id="n1">Reprint requests to: Richard C. Shelton, M.D., Vanderbilt University Medical Center, 1500 21st Avenue South, Suite 2200, Nashville, TN 37212-8646 (e-mail: <a class="oemail" data-email="ude.tlibrednav.liamcm@notlehs.drahcir" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC181183/#s3title/mailto:dev@null">ude.tlibrednav.liamcm@notlehs.drahcir</a>).</div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm140192409910640_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2001 May 14; Accepted 2001 Jun 28.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm140192409910640_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="https://www.ncbi.nlm.nih.gov/pmc/about/copyright/">Copyright</a>  © 2001, Physicians Postgraduate Press, Inc.</div></div></div><div class="links-box whole_rhythm" id="pmclinksbox"><div class="fm-panel"><div>This article has been <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC181183/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div class="tsec sec" id="idm140192431959952" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a aria-expanded="false" aria-haspopup="true" class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/#" role="menuitem" title="Go to other sections in this page">Go to:</a></span></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140192431959952title">Abstract</h2><div><p class="p p-first-last" id="__p2">Depressive disorders require long-term treatment with antidepressants, psychotherapy, or both. The goal of antidepressant therapy is complete remission of symptoms and return to normal daily functioning. Studies have shown that achieving remission and continuing antidepressant therapy long after the acute symptoms remit can protect against the relapse or recurrence of the psychiatric episode. Many patients, however, inadvertently or intentionally skip doses of their antidepressant, and even discontinue it, if their symptoms improve or if they experience side effects. Antidepressant discontinuation may increase the risk of relapse or precipitate certain distressing symptoms such as gastrointestinal complaints, dizziness, flu-like symptoms, equilibrium disturbances, and sleep disorders. Documented with all classes of antidepressants, these reactions may emerge within a couple of days, or even hours, after the abrupt discontinuation of an antidepressant with a short half-life. These distressing responses may be mistaken for a relapse or recurrence. It is important to recognize the potential for these sequelae and educate patients about the need to take all antidepressants at the doses prescribed, warning them of the symptoms that may occur if they skip doses or stop their medication too quickly. Antidepressants should be tapered slowly over a period of days, weeks, or even months, depending on the dose, duration of treatment, and pharmacologic properties of the agent, as well as the patient's individual response. This article reviews the risks and reactions associated with discontinuation of antidepressants. It offers guidelines for distinguishing relapse and recurrence from discontinuation responses as well as for prevention and management of the antidepressant discontinuation syndrome.</p></div></div><div class="tsec sec headless whole_rhythm" id="s1"><p class="p p-first" id="__p3">Major depression is a chronic condition with a naturally fluctuating course. Eventually, symptoms recur in half or more of patients.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b1" id="__tag_161251726" rid="i1523-5998-003-04-0168-b1" role="button">1,</a></sup><sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b2" id="__tag_161251727" rid="i1523-5998-003-04-0168-b2" role="button">2</a></sup> Numerous classes of antidepressant agents can successfully reduce depressive symptoms within several weeks, but this early improvement represents an acute response to treatment rather than a true remission.</p><p id="__p4">The goal of antidepressant therapy is not just to reduce or eliminate the acute symptoms but also to achieve full remission—i.e., the complete relief of symptoms and the restoration of social and occupational functioning—and to maintain remission for as long as possible.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b2" id="__tag_161251728" rid="i1523-5998-003-04-0168-b2" role="button">2–4</a></sup> Studies have shown that long-term use of antidepressants can protect against relapse (an early return or worsening of symptoms) and recurrence (later episodes occurring after remission) of depressive symptoms.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b4" id="__tag_161251697" rid="i1523-5998-003-04-0168-b4" role="button">4–6</a></sup> Evidence also shows that recurrences are more common and develop earlier in patients who continue to experience residual symptoms than in patients who have achieved full remission.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b7" id="__tag_161251690" rid="i1523-5998-003-04-0168-b7" role="button">7,</a></sup><sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b8" id="__tag_161251706" rid="i1523-5998-003-04-0168-b8" role="button">8</a></sup> Discontinuation of antidepressant treatment too soon after an initial acute response may, therefore, increase the risk of relapse or recurrence.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b3" id="__tag_161251708" rid="i1523-5998-003-04-0168-b3" role="button">3,</a></sup><sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b4" id="__tag_161251675" rid="i1523-5998-003-04-0168-b4" role="button">4</a></sup></p><p id="__p5">Antidepressant discontinuation at any stage of treatment can cause a variety of somatic and psychological reactions, especially if the withdrawal is abrupt. Although first identified 30 years ago with tricyclic antidepressants (TCAs), these symptoms are not unique to TCAs, having now been documented with all classes of antidepressants, including monoamine oxidase inhibitors (MAOIs), the serotonin reuptake inhibitors (SRIs) and selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and atypical agents (e.g., trazodone).<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b4" id="__tag_161251738" rid="i1523-5998-003-04-0168-b4" role="button">4,</a></sup><sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b9" id="__tag_161251674" rid="i1523-5998-003-04-0168-b9" role="button">9</a></sup> Discontinuation symptoms are often associated with rapid withdrawal, but they have been reported with gradual dose tapering and even after 1 or 2 skipped doses.</p><p class="p p-last" id="__p6">This review examines current recommendations for long-term maintenance therapy with antidepressants as well as the timing and rate of discontinuation. It also outlines the symptoms associated with discontinuation of antidepressants, their possible mechanisms, and recommendations for preventing or managing the antidepressant discontinuation syndrome.</p></div><div class="tsec sec" id="s2"><div class="goto jig-ncbiinpagenav-goto-container"><a aria-expanded="false" aria-haspopup="true" class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/#" role="button" title="Go to other sections in this page">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="s2title">WHEN TO DISCONTINUE ANTIDEPRESSANT THERAPY</h2><p class="p p-first" id="__p7">At some point in the treatment of mood disorders, the question of when to stop antidepressant treatment arises. Patients or physicians may opt to stop treatment after a symptomatic response is seen, after remission is achieved, after remission and functional improvements have been maintained for a reasonable amount of time, or when intolerable side effects occur or appear to outweigh the benefits of the drug.</p><p id="__p8">Since true remission, rather than partial symptomatic response, is the therapeutic goal, it is essential to determine if remission has occurred before stopping treatment. The severity of depression and the response to antidepressant therapy are assessed with a number of tools. The Hamilton Rating Scale for Depression (HAM-D) and the Clinical Global Impressions-Severity and -Improvement scales (CGI-S and CGI-I, respectively) are commonly used. Generally, a 50% reduction in the baseline HAM-D score and a CGI-I score of 1 (very much improved) or 2 (much improved) are considered to represent a good response to antidepressant treatment. However, these criteria may document symptomatic improvement but not necessarily remission. Minor symptoms may remain, increasing the risk of recurrence.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b3" id="__tag_161251693" rid="i1523-5998-003-04-0168-b3" role="button">3</a></sup> More stringent criteria have been proposed that distinguish true remission from acute symptomatic response or a placebo response. These new remission criteria require a HAM-D score of ≤ 7 (considered a return to normal functioning) and a CGI-I score of 1. The Sheehan Disability Scale may be used to assess improvements in function, with a score of ≤ 1 (mild disability) indicating a complete return to normal functioning in family, social, and work situations.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b3" id="__tag_161251678" rid="i1523-5998-003-04-0168-b3" role="button">3</a></sup> The Psychiatric Status Rating Scale may be used to evaluate recovery. Scores on this scale range from 1 (usual self, normal, no symptoms) to 6 (meets criteria for prominent symptoms or severe functional impairment). These and similar scales can be used in clinical practice to determine the return of normal functioning. The principle is that clinicians need to evaluate motivation and performance just as they would any other symptoms, such as sleep disturbance.</p><p id="__p9">Pharmacologic therapy should be continued long enough to sustain remission and avoid relapses and recurrences. Relapse refers to a return of symptoms during the time in which the original depressive episode would have been expected to last (4–9 months). Recurrence refers to a return of depression at a time beyond the expected duration of the index episode (&gt; 9 months after remission). This means that physicians and patients alike should not be too eager to discontinue medication prematurely. An interval of 6 months has been thought to be the usual duration of antidepressant therapy. New recommendations, however, suggest that treatment should continue for up to 9 months after symptoms have resolved (continuation phase) to prevent relapse and for longer to help prevent recurrence (maintenance phase).<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b3" id="__tag_161251684" rid="i1523-5998-003-04-0168-b3" role="button">3</a></sup> Some experts maintain that antidepressant treatment should continue for 3 to 5 years and possibly for life.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b1" id="__tag_161251711" rid="i1523-5998-003-04-0168-b1" role="button">1</a></sup></p><p class="p p-last" id="__p10">Like all drugs, antidepressants may cause a variety of side effects that in some cases are severe enough to necessitate a quick discontinuation and a switch to another medication.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b1" id="__tag_161251677" rid="i1523-5998-003-04-0168-b1" role="button">1</a></sup> Side effects, or the fear of side effects, may prompt patients to delay filling their antidepressant prescription or stop taking it as soon as their depressive symptoms begin to abate. Many patients take their antidepressant for 14 weeks or less.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b10" id="__tag_161251740" rid="i1523-5998-003-04-0168-b10" role="button">10</a></sup> The effects of antidepressant treatment, however, may not be fully evident for 6 to 8 weeks, and long-term treatment is needed to ensure complete recovery and to prevent recurrence. Nevertheless, patients who are experiencing adverse reactions may be apt to discontinue their antidepressant prematurely, never achieving full remission and increasing their risk of relapse or of discontinuation reactions.</p></div><div class="tsec sec" id="s3"><div class="goto jig-ncbiinpagenav-goto-container"><a aria-expanded="false" aria-haspopup="true" class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/#" role="button" title="Go to other sections in this page">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="s3title">RISKS ASSOCIATED WITH DISCONTINUING ANTIDEPRESSANT THERAPY</h2><p class="p p-first" id="__p11">The major risks after discontinuing an antidepressant include relapse or recurrence and discontinuation symptoms. These are quite distinct phenomena, with different causes and management implications.</p><div class="sec" id="s3a"><h3 id="s3atitle">Relapse or Recurrence</h3><p class="p p-first" id="__p12">Long-term antidepressant treatment can prolong remission and protect against recurrence.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b1" id="__tag_161251741" rid="i1523-5998-003-04-0168-b1" role="button">1,</a></sup><sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b4" id="__tag_161251672" rid="i1523-5998-003-04-0168-b4" role="button">4–6</a></sup> Discontinuing antidepressant treatment is associated with a shorter time to relapse and an increased incidence of recurrence.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b1" id="__tag_161251681" rid="i1523-5998-003-04-0168-b1" role="button">1,</a></sup><sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b10" id="__tag_161251664" rid="i1523-5998-003-04-0168-b10" role="button">10</a></sup> One factor that appears to increase the risk of relapse is the persistence of residual symptoms.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b7" id="__tag_161251722" rid="i1523-5998-003-04-0168-b7" role="button">7,</a></sup><sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b8" id="__tag_161251685" rid="i1523-5998-003-04-0168-b8" role="button">8</a></sup> In one 10-year follow-up of patients with major depressive disorder, those with residual symptoms had a recurrence 5 times sooner than did those who had achieved asymptomatic status; the asymptomatic patients experienced fewer relapses and longer symptom-free intervals.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b2" id="__tag_161251683" rid="i1523-5998-003-04-0168-b2" role="button">2</a></sup> Other factors predicting risk of relapse include a history of chronic depression<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b11" id="__tag_161251709" rid="i1523-5998-003-04-0168-b11" role="button">11</a></sup> and a history of multiple prior episodes.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b12" id="__tag_161251731" rid="i1523-5998-003-04-0168-b12" role="button">12</a></sup> In a study of 141 patients diagnosed with major depressive disorder, those patients with 3 or more prior episodes had significantly shorter intervals from recovery to relapse than did patients having fewer than 3 prior depressive episodes.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b12" id="__tag_161251737" rid="i1523-5998-003-04-0168-b12" role="button">12</a></sup></p><p class="p p-last" id="__p13">Age also is a predictive factor for recurrence: patients who had their first episode at an older age tend to relapse sooner than younger patients.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b1" id="__tag_161251747" rid="i1523-5998-003-04-0168-b1" role="button">1,</a></sup><sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b12" id="__tag_161251742" rid="i1523-5998-003-04-0168-b12" role="button">12,</a></sup><sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b13" id="__tag_161251723" rid="i1523-5998-003-04-0168-b13" role="button">13</a></sup> Another factor that increases the likelihood of recurrence is the concurrent presence of substance abuse or comorbid anxiety disorder.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b11" id="__tag_161251733" rid="i1523-5998-003-04-0168-b11" role="button">11</a></sup> A depressive relapse is more likely in the first weeks and months after recovery, with the risk declining with time.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b11" id="__tag_161251730" rid="i1523-5998-003-04-0168-b11" role="button">11,</a></sup><sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b12" id="__tag_161251686" rid="i1523-5998-003-04-0168-b12" role="button">12</a></sup> Continuing treatment is, therefore, especially crucial immediately after the acute resolution of symptoms.</p></div><div class="sec" id="s3b"><h3 id="s3btitle">Discontinuation Symptoms</h3><p class="p p-first" id="__p14">Discontinuing antidepressant medications can precipitate a variety of somatic and psychological reactions in patients. These reactions, often termed <em>antidepressant withdrawal</em> or <em>discontinuation syndrome</em>, have been noted with all classes of antidepressant agents including TCAs, MAOIs, SRIs, SSRIs, and SNRIs. Since antidepressants are not addictive agents and do not directly evoke the brain reward systems, the term “discontinuation” is preferred over “withdrawal” when describing these symptoms. Although discontinuation symptoms are most often associated with the abrupt discontinuation of an antidepressant, they have been reported during gradual tapering and intermittent noncompliance as well.</p><p id="__p15">Other risk factors associated with discontinuation reactions were reviewed by Lejoyeux and colleagues.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b14" rid="i1523-5998-003-04-0168-b14" role="button">14</a></sup> These include the use of concurrent long-term medications such as antihypertensives, anticonvulsants, and antihistamines. Antidepressant treatment lasting 2 months or more and, in some reports, young age were also factors.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b14" rid="i1523-5998-003-04-0168-b14" role="button">14</a></sup></p><p id="__p16"><a class="fig-table-link figpopup" co-legend-rid="" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC181183/table/i1523-5998-003-04-0168-t01/" rid-figpopup="i1523-5998-003-04-0168-t01" rid-ob="ob-i1523-5998-003-04-0168-t01" target="table"><span>Table 1</span></a> lists some of the symptoms associated with the discontinuation of TCAs and SRIs.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b15" id="__tag_161251719" rid="i1523-5998-003-04-0168-b15" role="button">15,</a></sup><sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b16" id="__tag_161251729" rid="i1523-5998-003-04-0168-b16" role="button">16</a></sup> Although much of the evidence for the discontinuation syndrome comes from case reports, controlled clinical trials involving the abrupt switch from active antidepressant to placebo also have documented the occurrence of these reactions.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b17" id="__tag_161251744" rid="i1523-5998-003-04-0168-b17" role="button">17</a></sup></p><div class="table-wrap table anchored whole_rhythm" id="i1523-5998-003-04-0168-t01"><h3>Table 1.</h3><div class="caption"><p id="__p43">Common Discontinuation Symptoms With Tricyclic Antidepressants and Serotonin Reuptake Inhibitors<sup>a</sup></p></div><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140192437641328"><a class="inline_block ts_canvas" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=181183_i1523-5998-003-04-0168-t01.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is i1523-5998-003-04-0168-t01.jpg" class="tileshop" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC181183/bin/i1523-5998-003-04-0168-t01.jpg" title="Click on image to zoom"/></a></div><div class="largeobj-link align_right" id="largeobj_idm140192437641328" style="display: none"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC181183/table/i1523-5998-003-04-0168-t01/?report=objectonly" target="object">Open in a separate window</a></div></div><p id="__p17">It is especially important to recognize the symptoms of discontinuation and distinguish them from relapse and recurrence because a misdiagnosis may lead to unnecessary tests, useless treatments, and increased costs.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b18" id="__tag_161251689" rid="i1523-5998-003-04-0168-b18" role="button">18</a></sup></p><p id="__p18">Gastrointestinal complaints are common, with patients frequently suffering from nausea, vomiting, abdominal pain and distention, and diarrhea.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b19" id="__tag_161251695" rid="i1523-5998-003-04-0168-b19" role="button">19,</a></sup><sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b20" id="__tag_161251724" rid="i1523-5998-003-04-0168-b20" role="button">20</a></sup> General somatic symptoms (e.g., sweating, lethargy, headaches, and a flu-like syndrome of chills, aches, and headaches), affective symptoms (e.g., anxiety, low mood), and sleep disorders (e.g., insomnia, vivid dreaming) are characteristic. Dizziness, balance problems, and sensory disturbances are also widely recognized with SSRI discontinuation.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b16" id="__tag_161251703" rid="i1523-5998-003-04-0168-b16" role="button">16,</a></sup><sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b19" id="__tag_161251713" rid="i1523-5998-003-04-0168-b19" role="button">19,</a></sup><sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b20" id="__tag_161251701" rid="i1523-5998-003-04-0168-b20" role="button">20</a></sup> Mania or hypomania, movement disorders such as parkinsonism and akathisia, and cardiac arrhythmias also have been reported with antidepressant cessation but are not as common as the mood, somatic, and sleep problems.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b9" id="__tag_161251669" rid="i1523-5998-003-04-0168-b9" role="button">9,</a></sup><sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b14" rid="i1523-5998-003-04-0168-b14" role="button">14,</a></sup><sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b16" id="__tag_161251705" rid="i1523-5998-003-04-0168-b16" role="button">16,</a></sup><sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b24" id="__tag_161251725" rid="i1523-5998-003-04-0168-b24" role="button">24</a></sup></p><p class="p p-last" id="__p19">The symptoms of discontinuation, although usually mild and transient, can range widely in severity.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b15" id="__tag_161251688" rid="i1523-5998-003-04-0168-b15" role="button">15</a></sup> Although the true incidence of discontinuation phenomena has not been established, these symptoms are believed to be common but not universal.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b22" rid="i1523-5998-003-04-0168-b22" role="button">22</a></sup> Some patients may be genetically or temperamentally more susceptible to these responses, while other patients may be better able to tolerate them.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b23" id="__tag_161251663" rid="i1523-5998-003-04-0168-b23" role="button">23</a></sup></p></div><div class="sec" id="s3c"><h3 id="s3ctitle">Class-Specific Symptoms</h3><p class="p p-first" id="__p20">Discontinuation symptoms differ among the antidepressant classes and even among the individual drugs within each class owing to the different mechanisms of action and the pharmacologic properties of the individual drugs.</p><div class="sec" id="s3c1"><p></p><h4 class="inline" id="s3c1title">TCAs. </h4><p class="p p-first-last" id="__p21">TCA discontinuation reactions have been reported within hours of even 1 missed dose of imipramine.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b15" id="__tag_161251682" rid="i1523-5998-003-04-0168-b15" role="button">15</a></sup> Typical responses to TCA discontinuation include abdominal pain, anorexia, nausea, vomiting, diarrhea, chills, fatigue, and weakness.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b14" rid="i1523-5998-003-04-0168-b14" role="button">14</a></sup> The symptoms of TCA discontinuation, believed to be related in part to an adaptive hypersensitivity of muscarinic cholinergic receptors, are called <em>cholinergic rebound</em> or <em>cholinergic overdrive</em>. Long-term administration of TCAs blocks muscarinic cholinergic receptors in the human caudate,<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b14" rid="i1523-5998-003-04-0168-b14" role="button">14,</a></sup><sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b24" id="__tag_161251734" rid="i1523-5998-003-04-0168-b24" role="button">24</a></sup> leading to a compensatory increase in the number of postsynaptic muscarinic receptors (up-regulation) and thus a supersensitivity to muscarinic agonists. Stopping the TCA unmasks this supersensitivity and may also disrupt the cholinergic-dopaminergic balance, contributing to the signs of parkinsonism and other balance disturbances that may occur with TCA discontinuation.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b14" rid="i1523-5998-003-04-0168-b14" role="button">14</a></sup> Similar to SSRIs, most SRIs and TCAs can produce discontinuation symptoms.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b23" id="__tag_161251721" rid="i1523-5998-003-04-0168-b23" role="button">23</a></sup></p></div><div class="sec" id="s3c2"><p></p><h4 class="inline" id="s3c2title">MAOIs. </h4><p class="p p-first-last" id="__p22">Discontinuation of MAOIs may cause severe and serious adverse events, including various types of cognitive impairment, aggression, catatonia, insomnia, irritability, paranoid delusions, depressed mood, and hallucinations (<a class="fig-table-link figpopup" co-legend-rid="" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC181183/table/i1523-5998-003-04-0168-t02/" rid-figpopup="i1523-5998-003-04-0168-t02" rid-ob="ob-i1523-5998-003-04-0168-t02" target="table"><span>Table 2</span></a>).<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b14" rid="i1523-5998-003-04-0168-b14" role="button">14</a></sup> These drugs down-regulate α<sub>2</sub>-adrenergic and dopaminergic receptors and possibly affect cholinergic receptors as well. MAOI withdrawal may stimulate the excessive release of both dopamine and norepinephrine via the removal of agonist activity on catecholamine receptors. Therefore, the symptoms can resemble those of amphetamine withdrawal.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b14" rid="i1523-5998-003-04-0168-b14" role="button">14,</a></sup><sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b25" id="__tag_161251716" rid="i1523-5998-003-04-0168-b25" role="button">25,</a></sup><sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b26" id="__tag_161251671" rid="i1523-5998-003-04-0168-b26" role="button">26</a></sup> In 1 report, reducing the dose of tranylcypromine precipitated depressive episodes that were said to be worse than the depression for which the 5 patients were being treated; discontinuation also caused cognitive disturbances.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b27" id="__tag_161251702" rid="i1523-5998-003-04-0168-b27" role="button">27</a></sup></p><div class="table-wrap table anchored whole_rhythm" id="i1523-5998-003-04-0168-t02"><h3>Table 2.</h3><div class="caption"><p id="__p44">Symptoms Reported After MAOI Discontinuation<sup>a</sup></p></div><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140192410113440"><a class="inline_block ts_canvas" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=181183_i1523-5998-003-04-0168-t02.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is i1523-5998-003-04-0168-t02.jpg" class="tileshop" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC181183/bin/i1523-5998-003-04-0168-t02.jpg" title="Click on image to zoom"/></a></div><div class="largeobj-link align_right" id="largeobj_idm140192410113440" style="display: none"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC181183/table/i1523-5998-003-04-0168-t02/?report=objectonly" target="object">Open in a separate window</a></div></div></div><div class="sec" id="s3c3"><p></p><h4 class="inline" id="s3c3title">SRIs and SSRIs. </h4><p class="p p-first" id="__p23">The SRIs and SSRIs block serotonin reuptake, increasing the amount of synaptic serotonin; this increase in available serotonin leads to a compensatory decrease in the number of some postsynaptic serotonin receptors (down-regulation).<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b17" id="__tag_161251736" rid="i1523-5998-003-04-0168-b17" role="button">17</a></sup> When the SSRI is discontinued abruptly, reuptake is reestablished (and possibly enhanced transiently), lowering the amount of available serotonin within the synapse. The resulting reduced concentration of available serotonin, plus the receptor down-regulation, causes clinical signs of serotonin deficiency. Since serotonin interacts with numerous other neurotransmitter systems, its deficiency has the potential to disrupt many other neuronal functions.</p><p id="__p24">SSRI discontinuation symptoms are similar to those of the TCAs, with dizziness, gastrointestinal symptoms, and sleep disorders common. Anecdotal reports have included complaints of “electric shock–like” sensations, flashes, and “withdrawal buzz.”<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b15" id="__tag_161251712" rid="i1523-5998-003-04-0168-b15" role="button">15,</a></sup><sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b17" id="__tag_161251718" rid="i1523-5998-003-04-0168-b17" role="button">17,</a></sup><sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b18" id="__tag_161251700" rid="i1523-5998-003-04-0168-b18" role="button">18,</a></sup><sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b23" id="__tag_161251748" rid="i1523-5998-003-04-0168-b23" role="button">23–26,</a></sup><sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b28" id="__tag_161251749" rid="i1523-5998-003-04-0168-b28" role="button">28–32</a></sup> The type and severity of the symptoms correlate with the relative affinities of the agents for the serotonin reuptake sites and with secondary effects on other neurotransmitters; with SRIs that also affect cholinergic systems, the symptoms possibly correlate with cholinergic rebound.</p><p id="__p25">Sudden discontinuation is a particular problem with agents that have a relatively short half-life, which include the SSRI paroxetine and the SNRI venlafaxine. With these types of drug, the symptoms can last up to 2 weeks.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b29" id="__tag_161251694" rid="i1523-5998-003-04-0168-b29" role="button">29</a></sup> A randomized clinical trial reported that in the 5 to 8 days after discontinuation of an SSRI, symptoms were most common with paroxetine—the most potent SSRI and one with a short half-life—and least common with fluoxetine—an SSRI with a lower serotonin reuptake affinity and a longer half-life.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b31" id="__tag_161251673" rid="i1523-5998-003-04-0168-b31" role="button">31</a></sup> Reactions to sertraline were mild and infrequent. However, this trial was designed to simulate intermittent noncompliance and did not attempt to document late-emerging effects that might occur with a drug with a long half-life, such as fluoxetine. There have been reports of symptoms starting 25 days after fluoxetine withdrawal with some persisting as long as 56 days.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b29" id="__tag_161251720" rid="i1523-5998-003-04-0168-b29" role="button">29</a></sup> Late reactions to fluoxetine cessation may be reported less often because trials do not follow patients long enough after withdrawal to observe them. Further, the symptoms may be mild and patients may not attribute general symptoms such as flu-like complaints, dizziness, or sleep disturbances to a drug they had stopped taking weeks earlier.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b29" id="__tag_161251715" rid="i1523-5998-003-04-0168-b29" role="button">29</a></sup></p><p class="p p-last" id="__p26">In addition to its effects on serotonin reuptake, paroxetine affects muscarinic receptors, and its withdrawal could contribute to symptoms of cholinergic rebound, a mechanism usually not attributed to other SSRIs.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b23" id="__tag_161251699" rid="i1523-5998-003-04-0168-b23" role="button">23</a></sup> One case report of a patient discontinuing low-dose paroxetine (10 to 20 mg/day) noted symptoms that were very disabling initially and lasted longer than the 5 to 15 days mentioned in the prescribing information. The responses included agitation, anorexia, nausea and diarrhea, vertigo and dizziness, paresthesia, and a shaking chill.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b30" id="__tag_161251746" rid="i1523-5998-003-04-0168-b30" role="button">30</a></sup> Sertraline, which like paroxetine is associated with a higher occurrence of discontinuation reactions, is the only SSRI that strongly blocks dopamine reuptake as well as serotonin-reuptake sites.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b23" id="__tag_161251707" rid="i1523-5998-003-04-0168-b23" role="button">23</a></sup> Further, discontinuation symptoms with sertraline, although usually mild, may be related to its effect on both dopamine and serotonin reuptake.</p></div><div class="sec sec-last" id="s3cd"><p></p><h4 class="inline" id="s3cdtitle">SNRIs. </h4><p class="p p-first" id="__p27">The therapeutic effectiveness of the SNRI venlafaxine is related to its dual inhibition of serotonin and norepinephrine reuptake. These actions stimulate a down-regulation of serotonergic and adrenergic receptors. Venlafaxine also weakly inhibits dopamine reuptake but has no significant affinity for muscarinic, histaminergic, or adrenergic receptors. Considering its relative lack of affinity for muscarinic cholinergic receptors, discontinuation symptoms associated with venlafaxine are probably not attributed to a cholinergic rebound phenomenon.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b33" id="__tag_161251679" rid="i1523-5998-003-04-0168-b33" role="button">33</a></sup></p><p class="p p-last" id="__p28">A decrease in venlafaxine dose over 4 days to 2 weeks in a small sample of patients caused a flu-like syndrome with muscle pain, headaches, nausea, and dizziness.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b34" id="__tag_161251710" rid="i1523-5998-003-04-0168-b34" role="button">34</a></sup> Eight patients in an open-label study reported discontinuation symptoms of rebound anxiety, vertigo, headache, nausea, tachycardia, tinnitus, and akathisia starting about 12 hours after discontinuing venlafaxine. For most patients, the dose was reduced gradually over 7 to 14 days, and the symptoms peaked in severity 4 days after the complete discontinuation before gradually dissipating.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b28" id="__tag_161251698" rid="i1523-5998-003-04-0168-b28" role="button">28</a></sup></p></div></div><div class="sec sec-last" id="s3d"><h3 id="s3dtitle">Distinguishing Discontinuation Syndrome From Relapse and Recurrence</h3><p class="p p-first" id="__p29">The nature of the symptoms and the time course of their emergence can help in distinguishing discontinuation syndrome from relapse or recurrence. Discontinuation reactions may be physical as well as psychological, and they are usually not attributable to other causes. A distinctive symptom of discontinuation is dizziness, which is not characteristic of relapse and can often therefore be used in making the differentiation.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b35" rid="i1523-5998-003-04-0168-b35" role="button">35</a></sup> Although discontinuation responses are generally mild, they can be severe, interfering with home, work, and daily activities such as driving. If symptoms of discontinuation emerge, they can be reversed by restarting the original antidepressant or a similar medication, which should then be slowly tapered to minimize the recurrence of the symptoms. Symptoms of relapse or remission are not so readily reversed.</p><p id="__p30">The time course of the appearance of the symptoms also gives a clue as to their origin. Discontinuation-emergent reactions occur after abrupt discontinuation of the antidepressant or frequently missed doses, although they may occur as the dose is being reduced.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b32" rid="i1523-5998-003-04-0168-b32" role="button">32</a></sup> The symptoms emerge within a couple of days—sometimes hours—of discontinuation and gradually remit over a few days to 2 weeks. In contrast, relapse or recurrence typically takes 2 or 3 weeks or longer after the medication is discontinued to emerge, and these events are heralded by worsening depression, insomnia, and psychomotor symptoms.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b18" id="__tag_161251735" rid="i1523-5998-003-04-0168-b18" role="button">18</a></sup></p><p class="p p-last" id="__p31">Owing to their antidepressant and anxiolytic properties, newer antidepressant drugs such as the SSRIs and SNRIs also are being widely prescribed for anxiety disorders. The SSRIs have demonstrated efficacy for several anxiety disorders, including obsessive-compulsive disorder, panic disorder, generalized anxiety disorder (GAD), and social anxiety disorder.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b36" id="__tag_161251745" rid="i1523-5998-003-04-0168-b36" role="button">36</a></sup> Venlafaxine XR (extended release) and paroxetine are the only antidepressants to receive U.S. Food and Drug Administration (FDA) approval for the treatment of GAD. The antidepressant and anxiolytic efficacy of these drugs can be attributed to their serotonin reuptake properties, which relate to their propensity for discontinuation effects. The relative contribution of the noradrenergic action of venlafaxine XR to its anxiolytic effect is unclear.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b37" id="__tag_161251676" rid="i1523-5998-003-04-0168-b37" role="button">37,</a></sup><sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b38" rid="i1523-5998-003-04-0168-b38" role="button">38</a></sup> It is not known whether discontinuing these medications among patients with anxiety disorders will result in the same somatic and psychological reactions as seen in patients with depression. Further research is needed.</p></div></div><div class="tsec sec" id="s4"><div class="goto jig-ncbiinpagenav-goto-container"><a aria-expanded="false" aria-haspopup="true" class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/#" role="button" title="Go to other sections in this page">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="s4title">ANTIDEPRESSANT DISCONTINUATION: RECOMMENDATIONS FOR DOSAGE TAPERING</h2><p class="p p-first" id="__p32">Unfortunately, no drug-specific protocols for discontinuing antidepressants have been established. Prescribing information for each drug typically lacks recommendations for the rate and duration of tapering or criteria for antidepressant discontinuation. A review of the literature on these phenomena, however, shows that a slow taper is uniformly recommended.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b14" rid="i1523-5998-003-04-0168-b14" role="button">14,</a></sup><sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b15" id="__tag_161251696" rid="i1523-5998-003-04-0168-b15" role="button">15,</a></sup><sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b18" id="__tag_161251670" rid="i1523-5998-003-04-0168-b18" role="button">18</a></sup> Inasmuch as antidepressant treatment generally continues for months to years, so should the taper be accorded adequate time to take effect. Several months may be required, depending on the dose, the pharmacologic profile of the drug, the duration of treatment, and the response of the patient.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b15" id="__tag_161251692" rid="i1523-5998-003-04-0168-b15" role="button">15</a></sup></p><p id="__p33">Because there has been little research on the ideal rates for antidepressant discontinuation, published recommendations for taper rates are often vague.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b39" id="__tag_161251739" rid="i1523-5998-003-04-0168-b39" role="button">39</a></sup> Consequently, the magnitude and speed of the dose reduction are often left to clinical judgment. Some specific recommendations have been reported (<a class="fig-table-link figpopup" co-legend-rid="" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC181183/table/i1523-5998-003-04-0168-t03/" rid-figpopup="i1523-5998-003-04-0168-t03" rid-ob="ob-i1523-5998-003-04-0168-t03" target="table"><span>Table 3</span></a>).<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b14" rid="i1523-5998-003-04-0168-b14" role="button">14,</a></sup><sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b18" id="__tag_161251680" rid="i1523-5998-003-04-0168-b18" role="button">18,</a></sup><sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b25" id="__tag_161251717" rid="i1523-5998-003-04-0168-b25" role="button">25,</a></sup><sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b40" rid="i1523-5998-003-04-0168-b40" role="button">40</a></sup> For example, MAOI dosages should not usually be reduced by more than 10% per week, and patients should be monitored carefully. TCAs should be reduced with great care over at least 2 to 3 months; if symptoms occur, the dose should be increased and the taper started again at a slower rate. With TCAs, it may be advisable to slow the taper even more near the end of the discontinuation phase.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b14" rid="i1523-5998-003-04-0168-b14" role="button">14</a></sup></p><div class="table-wrap table anchored whole_rhythm" id="i1523-5998-003-04-0168-t03"><h3>Table 3.</h3><div class="caption"><p id="__p45">Gradual Taper Rates for Antidepressants<sup>a</sup></p></div><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140192412118656"><a class="inline_block ts_canvas" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=181183_i1523-5998-003-04-0168-t03.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is i1523-5998-003-04-0168-t03.jpg" class="tileshop" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC181183/bin/i1523-5998-003-04-0168-t03.jpg" title="Click on image to zoom"/></a></div><div class="largeobj-link align_right" id="largeobj_idm140192412118656" style="display: none"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC181183/table/i1523-5998-003-04-0168-t03/?report=objectonly" target="object">Open in a separate window</a></div></div><p class="p p-last" id="__p34">Since the therapeutic dosage levels of individual SSRIs vary so widely, their taper rate varies as well; however, gradual tapering also is recommended for this group of agents. A long half-life itself may provide a form of self-tapering but is not an absolute protection against discontinuation symptoms. For venlafaxine, even a taper regimen lasting 7 to 14 days induced symptoms of discontinuation in several patients in 1 of the clinical trials. The investigators therefore recommended that the drug be reduced over a minimum of 2 to 4 weeks (the prescribing information recommends a 2-week tapering for any patient treated for more than 1 week).<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b28" id="__tag_161251704" rid="i1523-5998-003-04-0168-b28" role="button">28</a></sup> Recently, the British National Formulary recommended a 4-week gradual dose reduction for any antidepressant prescribed for 2 months or more.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b19" id="__tag_161251732" rid="i1523-5998-003-04-0168-b19" role="button">19</a></sup> The final step in the dosage taper may be lower than the minimum therapeutic or the initial treatment dose.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b18" id="__tag_161251665" rid="i1523-5998-003-04-0168-b18" role="button">18</a></sup></p></div><div class="tsec sec" id="s5"><div class="goto jig-ncbiinpagenav-goto-container"><a aria-expanded="false" aria-haspopup="true" class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/#" role="button" title="Go to other sections in this page">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="s5title">PREVENTION AND MANAGEMENT OF DISCONTINUATION SYMPTOMS</h2><p class="p p-first" id="__p35">Prevention is the best strategy for avoiding or minimizing discontinuation symptoms. Since some cases of discontinuation syndrome are due to missed doses or premature discontinuation by the patient, the first management goal is patient education. At the initiation of treatment, patients need to understand the chronic nature and fluctuating course of their symptoms and know that their symptoms will probably regress slowly over time. They should not consider symptom improvement as a cure, nor should they interpret the persistence of minor symptoms as a sign that treatment is ineffective. The goal of remission should be emphasized during patient encounters, and the need to continue treatment for months or even years should be explained thoroughly. As their symptoms remit and they begin to feel better, patients may wonder why they should continue taking their medication, especially if they are experiencing adverse reactions to the antidepressant. They may pressure their physicians into considering discontinuation of the drug. Since premature discontinuation can lead to both relapse and discontinuation reactions, the physician should ensure that patients understand that they must continue to take their medication, in the doses prescribed, for as long as necessary to achieve a true remission and avoid or delay recurrence. Antidepressant “vacations” should be discouraged, especially with antidepressants that have a short half-life, as even brief interruptions in therapy may precipitate an episode of discontinuation reactions.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b16" id="__tag_161251666" rid="i1523-5998-003-04-0168-b16" role="button">16</a></sup> Patients suffering from discontinuation symptoms may attribute them to a direct side effect of the antidepressant and resist restarting the medication.</p><p id="__p36">Physicians must consider the possibility of noncompliance when they encounter symptoms that might be related to antidepressant discontinuation. Asking patients if they have missed any doses may help avoid unnecessary tests and treatments as well as help initiate a discussion of the risks associated with stopping medication prematurely. Knowing the nature and duration of symptoms, plus obtaining information about noncompliance, can help differentiate discontinuation reactions from side effects and recurrences.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b41" id="__tag_161251668" rid="i1523-5998-003-04-0168-b41" role="button">41</a></sup></p><p class="p p-last" id="__p37">Discontinuation symptoms occur even with a careful and gradual taper. They can be managed with several options. For mild symptoms, education and reassurance may be adequate.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b18" id="__tag_161251687" rid="i1523-5998-003-04-0168-b18" role="button">18</a></sup> Symptoms can be reversed by restoring the antidepressant (or starting a similar antidepressant) and starting the taper again, reducing the dose in smaller increments during longer intervals. If restarting the antidepressant is not feasible for safety or tolerability reasons, other agents may be used to relieve the symptoms. Anticholinergic agents (e.g., benztropine, trihexyphenidyl) will improve the gastrointestinal symptoms, anxiety, sleep problems, and somatic reactions associated with the discontinuation of anticholinergic drugs such as the TCAs.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b41" id="__tag_161251691" rid="i1523-5998-003-04-0168-b41" role="button">41,</a></sup><sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b42" id="__tag_161251714" rid="i1523-5998-003-04-0168-b42" role="button">42</a></sup> Anxiety can be managed with a benzodiazepine and dizziness relieved with motion sickness agents (e.g., meclizine, dimenhydrinate). Propranolol can be used for akathisia, benzodiazepines for dyskinesia, and anticholinergic agents or antihistamines for dystonia, should these more serious reactions occur.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b42" id="__tag_161251667" rid="i1523-5998-003-04-0168-b42" role="button">42</a></sup></p></div><div class="tsec sec" id="s6"><div class="goto jig-ncbiinpagenav-goto-container"><a aria-expanded="false" aria-haspopup="true" class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/#" role="button" title="Go to other sections in this page">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="s6title">CONCLUSION</h2><p class="p p-first" id="__p38">Gastrointestinal complaints, dizziness, flu-like symptoms, sleep disorders, balance and sensory disorders, affective symptoms, and other reactions have been seen with the discontinuation of all classes of antidepressants. Antidepressant discontinuation symptoms typically emerge within a few days of drug discontinuation. Although sometimes very distressing, the symptoms are rarely serious and will dissipate within about 2 weeks. Reactions to MAOI withdrawal, however, may be more severe. Discontinuation symptoms can best be prevented or minimized by allowing neural adaptation to the loss of the drug to occur gradually, with careful and deliberate drug tapers over a few weeks to a few months. Specific discontinuation protocols for some of the new antidepressants such as venlafaxine may be found in the prescribing information published in the <em>Physicians' Desk Reference</em>.<sup><a aria-expanded="false" aria-haspopup="true" class="bibr popnode" href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b40" rid="i1523-5998-003-04-0168-b40" role="button">40</a></sup> However, until data from systematic controlled studies are available, the case report literature offers some insight and suggestions, however vague, on the management and prevention of discontinuation symptoms.</p><p id="__p39">More controlled studies on this common phenomenon are needed. For now, physicians must remind patients who suffer from depressive and anxiety disorders that the goal of antidepressant therapy is remission and that definite and immediate risks are associated with abruptly stopping antidepressant therapy, even for brief periods, or prematurely discontinuing treatment. Therefore, it is important for psychiatrists and primary care physicians to question patients about emerging discontinuation symptoms to ensure optimal management of treatment discontinuation and to prevent the emergence of additional discontinuation symptoms.</p><p class="p p-last" id="__p40"><em>Drug names:</em> benztropine (Cogentin and others), fluvoxamine (Luvox), fluoxetine (Prozac and others), meclizine (Antivert, Bonine, and others), paroxetine (Paxil), phenelzine (Nardil), propranolol (Inderal and others), sertraline (Zoloft), tranylcypromine (Parnate), trazodone (Desyrel and others), trihexyphenidyl (Artane and others), venlafaxine (Effexor).</p></div><div class="tsec sec" id="idm140192429824800"><div class="goto jig-ncbiinpagenav-goto-container"><a aria-expanded="false" aria-haspopup="true" class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/#" role="button" title="Go to other sections in this page">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140192429824800title">Footnotes</h2><div class="fm-sec half_rhythm small"><p class="fn sec" id="n2"></p><p class="p p-first-last" id="__p41">Supported by an unrestricted educational grant from Wyeth-Ayerst Laboratories, Philadelphia, Pa.</p><p></p><p class="fn sec" id="n3"></p><p class="p p-first-last" id="__p42">Dr. Shelton has received grant/research support from Eli Lilly, Glaxo, Janssen, Pfizer, Roehn-Polenc-Rorer, Sanofi, SmithKline Beecham, Wyeth-Ayerst, Zeneca, and Abbott; is a paid consultant for Pfizer and Janssen; and serves on the speakers bureau for Bristol-Meyers Squibb, Eli Lilly, Janssen, Pfizer, SmithKline Beecham, Solvay, Wyeth-Ayerst, and Abbott.</p><p></p></div></div><div class="tsec sec" id="idm140192438980048"><div class="goto jig-ncbiinpagenav-goto-container"><a aria-expanded="false" aria-haspopup="true" class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/#" role="button" title="Go to other sections in this page">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140192438980048title">REFERENCES</h2><div class="ref-list-sec sec" id="reference-list"><ul class="back-ref-list" style="list-style-type:decimal;"><li id="i1523-5998-003-04-0168-b1"><span class="citation">Keller MB, Lavori PW, Mueller TI, et al. Time to recovery, chronicity, and levels of psychopathology in major depression: a 5-year prospective follow-up of 431 subjects. <span><span class="ref-journal">Arch Gen Psychiatry. </span>1992;<span class="ref-vol">49</span>:809–816.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/1417434" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Arch+Gen+Psychiatry&amp;title=Time+to+recovery,+chronicity,+and+levels+of+psychopathology+in+major+depression:+a+5-year+prospective+follow-up+of+431+subjects&amp;author=MB+Keller&amp;author=PW+Lavori&amp;author=TI+Mueller&amp;author=+et+al&amp;volume=49&amp;publication_year=1992&amp;pages=809-816&amp;pmid=1417434&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b2"><span class="citation">Judd LL, Akiskal HS. Delineating the longitudinal structure of depressive illness: beyond clinical subtypes and duration thresholds. <span><span class="ref-journal">Pharmacopsychiatry. </span>2000;<span class="ref-vol">33</span>:3–7.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/10721877" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Pharmacopsychiatry&amp;title=Delineating+the+longitudinal+structure+of+depressive+illness:+beyond+clinical+subtypes+and+duration+thresholds&amp;author=LL+Judd&amp;author=HS+Akiskal&amp;volume=33&amp;publication_year=2000&amp;pages=3-7&amp;pmid=10721877&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b3"><span class="citation">Ballenger JC. Clinical guidelines for establishing remission in patients with depression and anxiety. <span><span class="ref-journal">J Clin Psychiatry. </span>1999;<span class="ref-vol">60</span>(suppl 22):29–34.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/10634353" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Psychiatry&amp;title=Clinical+guidelines+for+establishing+remission+in+patients+with+depression+and+anxiety&amp;author=JC+Ballenger&amp;volume=60&amp;issue=suppl+22&amp;publication_year=1999&amp;pages=29-34&amp;pmid=10634353&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b4"><span class="citation">Entsuah AR, Rudolph RL, Hackett D, et al. Efficacy of venlafaxine and placebo during long-term treatment of depression: a pooled analysis of relapse rates. <span><span class="ref-journal">Int Clin Psychopharmacol. </span>1996;<span class="ref-vol">11</span>:137–145.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/8803651" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Int+Clin+Psychopharmacol&amp;title=Efficacy+of+venlafaxine+and+placebo+during+long-term+treatment+of+depression:+a+pooled+analysis+of+relapse+rates&amp;author=AR+Entsuah&amp;author=RL+Rudolph&amp;author=D+Hackett&amp;author=+et+al&amp;volume=11&amp;publication_year=1996&amp;pages=137-145&amp;pmid=8803651&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b5"><span class="citation">Frank E, Kupfer DJ, Perel JM, et al. Three-year outcomes for maintenance therapies in recurrent depression. <span><span class="ref-journal">Arch Gen Psychiatry. </span>1990;<span class="ref-vol">47</span>:1093–1099.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/2244793" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Arch+Gen+Psychiatry&amp;title=Three-year+outcomes+for+maintenance+therapies+in+recurrent+depression&amp;author=E+Frank&amp;author=DJ+Kupfer&amp;author=JM+Perel&amp;author=+et+al&amp;volume=47&amp;publication_year=1990&amp;pages=1093-1099&amp;pmid=2244793&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b6"><span class="citation">Terra JL, Montgomery SA. Fluvoxamine prevents recurrence of depression: results of a long-term, double-blind, placebo-controlled study. <span><span class="ref-journal">Int Clin Psychopharmacol. </span>1998;<span class="ref-vol">13</span>:55–62.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/9669185" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Int+Clin+Psychopharmacol&amp;title=Fluvoxamine+prevents+recurrence+of+depression:+results+of+a+long-term,+double-blind,+placebo-controlled+study&amp;author=JL+Terra&amp;author=SA+Montgomery&amp;volume=13&amp;publication_year=1998&amp;pages=55-62&amp;pmid=9669185&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b7"><span class="citation">Paykel ES, Ramana R, Cooper Z, et al. Residual symptoms after partial remission: an important outcome in depression. <span><span class="ref-journal">Psychol Med. </span>1995;<span class="ref-vol">25</span>:1171–1180.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/8637947" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Psychol+Med&amp;title=Residual+symptoms+after+partial+remission:+an+important+outcome+in+depression&amp;author=ES+Paykel&amp;author=R+Ramana&amp;author=Z+Cooper&amp;author=+et+al&amp;volume=25&amp;publication_year=1995&amp;pages=1171-1180&amp;pmid=8637947&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b8"><span class="citation">Paykel ES. Remission and residual symptomatology in major depression. <span><span class="ref-journal">Psychopathology. </span>1998;<span class="ref-vol">31</span>:5–14.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/9500681" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Psychopathology&amp;title=Remission+and+residual+symptomatology+in+major+depression&amp;author=ES+Paykel&amp;volume=31&amp;publication_year=1998&amp;pages=5-14&amp;pmid=9500681&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b9"><span class="citation">Lejoyeux M, Ades J. Antidepressant discontinuation: a review of the literature. <span><span class="ref-journal">J Clin Psychiatry. </span>1997;<span class="ref-vol">58</span>(suppl 7):11–16.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/9219488" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Psychiatry&amp;title=Antidepressant+discontinuation:+a+review+of+the+literature&amp;author=M+Lejoyeux&amp;author=J+Ades&amp;volume=58&amp;issue=suppl+7&amp;publication_year=1997&amp;pages=11-16&amp;pmid=9219488&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b10"><span class="citation">Keller MB, Boland RJ. Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression. <span><span class="ref-journal">Biol Psychiatry. </span>1998;<span class="ref-vol">44</span>:348–360.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/9755357" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Biol+Psychiatry&amp;title=Implications+of+failing+to+achieve+successful+long-term+maintenance+treatment+of+recurrent+unipolar+major+depression&amp;author=MB+Keller&amp;author=RJ+Boland&amp;volume=44&amp;publication_year=1998&amp;pages=348-360&amp;pmid=9755357&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b11"><span class="citation">NIMH/NIH Consensus Development Conference Statement. <span class="ref-title">Mood disorders: pharmacologic prevention of recurrences. Consensus Development Panel</span>. <span class="ref-journal">Am J Psychiatry</span>. 1985 <span class="ref-vol">142</span>:469–476. [<a href="https://www.ncbi.nlm.nih.gov/pubmed/3976921" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Am+J+Psychiatry&amp;title=Mood+disorders:+pharmacologic+prevention+of+recurrences.+Consensus+Development+Panel&amp;volume=142&amp;publication_year=1985&amp;pages=469-476&amp;pmid=3976921&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b12"><span class="citation">Keller MB, Lavori PW, Lewis CE, et al. Predictors of relapse in major depressive disorder. <span><span class="ref-journal">JAMA. </span>1983;<span class="ref-vol">250</span>:3299–3304.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/6645026" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Predictors+of+relapse+in+major+depressive+disorder&amp;author=MB+Keller&amp;author=PW+Lavori&amp;author=CE+Lewis&amp;author=+et+al&amp;volume=250&amp;publication_year=1983&amp;pages=3299-3304&amp;pmid=6645026&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b13"><span class="citation">Flint AJ, Rifat SL. Recurrence of first-episode geriatric depression after discontinuation of maintenance antidepressants. <span><span class="ref-journal">Am J Psychiatry. </span>1999;<span class="ref-vol">156</span>:943–945.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/10360137" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Am+J+Psychiatry&amp;title=Recurrence+of+first-episode+geriatric+depression+after+discontinuation+of+maintenance+antidepressants&amp;author=AJ+Flint&amp;author=SL+Rifat&amp;volume=156&amp;publication_year=1999&amp;pages=943-945&amp;pmid=10360137&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b14"><span class="citation">Lejoyeux M, Ades J, Mourad I, et al. Antidepressant withdrawal syndrome: recognition, prevention and management. <span><span class="ref-journal">CNS Drugs. </span>1996;<span class="ref-vol">5</span>:278–292.</span> <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=CNS+Drugs&amp;title=Antidepressant+withdrawal+syndrome:+recognition,+prevention+and+management&amp;author=M+Lejoyeux&amp;author=J+Ades&amp;author=I+Mourad&amp;author=+et+al&amp;volume=5&amp;publication_year=1996&amp;pages=278-292&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b15"><span class="citation">Dilsaver SC, Greden JF. Antidepressant withdrawal phenomena. <span><span class="ref-journal">Biol Psychiatry. </span>1984;<span class="ref-vol">19</span>:237–256.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/6324897" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Biol+Psychiatry&amp;title=Antidepressant+withdrawal+phenomena&amp;author=SC+Dilsaver&amp;author=JF+Greden&amp;volume=19&amp;publication_year=1984&amp;pages=237-256&amp;pmid=6324897&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b16"><span class="citation">Thompson C. Discontinuation of antidepressant therapy: emerging complications and their relevance. <span><span class="ref-journal">J Clin Psychiatry. </span>1998;<span class="ref-vol">59</span>:541–548.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/9818638" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Psychiatry&amp;title=Discontinuation+of+antidepressant+therapy:+emerging+complications+and+their+relevance&amp;author=C+Thompson&amp;volume=59&amp;publication_year=1998&amp;pages=541-548&amp;pmid=9818638&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b17"><span class="citation">Zajecka J, Tracy KA, Mitchell S. Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review. <span><span class="ref-journal">J Clin Psychiatry. </span>1997;<span class="ref-vol">58</span>:291–297.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/9269249" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Psychiatry&amp;title=Discontinuation+symptoms+after+treatment+with+serotonin+reuptake+inhibitors:+a+literature+review&amp;author=J+Zajecka&amp;author=KA+Tracy&amp;author=S+Mitchell&amp;volume=58&amp;publication_year=1997&amp;pages=291-297&amp;pmid=9269249&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b18"><span class="citation">Rosenbaum JF, Zajecka J. Clinical management of antidepressant discontinuation. <span><span class="ref-journal">J Clin Psychiatry. </span>1997;<span class="ref-vol">58</span>(suppl 7):37–40.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/9219493" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Psychiatry&amp;title=Clinical+management+of+antidepressant+discontinuation&amp;author=JF+Rosenbaum&amp;author=J+Zajecka&amp;volume=58&amp;issue=suppl+7&amp;publication_year=1997&amp;pages=37-40&amp;pmid=9219493&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b19"><span class="citation">Haddad P, Lejoyeux M, Young A. Antidepressant discontinuation reactions [editorial] <span><span class="ref-journal">BMJ. </span>1998;<span class="ref-vol">316</span>:1105–1106.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1112935/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/9552943" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=BMJ&amp;title=Antidepressant+discontinuation+reactions+[editorial]&amp;author=P+Haddad&amp;author=M+Lejoyeux&amp;author=A+Young&amp;volume=316&amp;publication_year=1998&amp;pages=1105-1106&amp;pmid=9552943&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b20"><span class="citation">Louie AK, Lannon RA, Ajari LJ. Withdrawal reaction after sertraline discontinuation. <span><span class="ref-journal">Am J Psychiatry. </span>1994;<span class="ref-vol">151</span>:450–451.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/8109661" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Am+J+Psychiatry&amp;title=Withdrawal+reaction+after+sertraline+discontinuation&amp;author=AK+Louie&amp;author=RA+Lannon&amp;author=LJ+Ajari&amp;volume=151&amp;publication_year=1994&amp;pages=450-451&amp;pmid=8109661&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b21"><span class="citation">Hartmann PM. Mania or hypomania after withdrawal from antidepressants. <span><span class="ref-journal">J Fam Pract. </span>1990;<span class="ref-vol">30</span>:471–472.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/2324698" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Fam+Pract&amp;title=Mania+or+hypomania+after+withdrawal+from+antidepressants&amp;author=PM+Hartmann&amp;volume=30&amp;publication_year=1990&amp;pages=471-472&amp;pmid=2324698&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b22"><span class="citation">Khan A. Three cases of adverse symptoms occurring after the discontinuation of venlafaxine [letter] <span><span class="ref-journal">Psychiatr Ann. </span>1997;<span class="ref-vol">27</span>:259.</span> <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Psychiatr+Ann&amp;title=Three+cases+of+adverse+symptoms+occurring+after+the+discontinuation+of+venlafaxine+[letter]&amp;author=A+Khan&amp;volume=27&amp;publication_year=1997&amp;pages=259&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b23"><span class="citation">Schatzberg AF, Haddad P, Kaplan EM, et al. Possible biological mechanisms of the serotonin reuptake inhibitor discontinuation syndrome. <span><span class="ref-journal">J Clin Psychiatry. </span>1997;<span class="ref-vol">58</span>(suppl 7):23–27.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/9219490" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Psychiatry&amp;title=Possible+biological+mechanisms+of+the+serotonin+reuptake+inhibitor+discontinuation+syndrome&amp;author=AF+Schatzberg&amp;author=P+Haddad&amp;author=EM+Kaplan&amp;author=+et+al&amp;volume=58&amp;issue=suppl+7&amp;publication_year=1997&amp;pages=23-27&amp;pmid=9219490&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b24"><span class="citation">Dilsaver SC. Antidepressant withdrawal syndromes: phenomenology and pathophysiology. <span><span class="ref-journal">Acta Psychiatr Scand. </span>1989;<span class="ref-vol">79</span>:113–117.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/2923004" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Acta+Psychiatr+Scand&amp;title=Antidepressant+withdrawal+syndromes:+phenomenology+and+pathophysiology&amp;author=SC+Dilsaver&amp;volume=79&amp;publication_year=1989&amp;pages=113-117&amp;pmid=2923004&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b25"><span class="citation">Dilsaver SC. Withdrawal phenomena associated with antidepressant and antipsychotic agents. <span><span class="ref-journal">Drug Saf. </span>1994;<span class="ref-vol">10</span>:103–114.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/7912078" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Drug+Saf&amp;title=Withdrawal+phenomena+associated+with+antidepressant+and+antipsychotic+agents&amp;author=SC+Dilsaver&amp;volume=10&amp;publication_year=1994&amp;pages=103-114&amp;pmid=7912078&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b26"><span class="citation">Dilsaver SC. Heterocyclic antidepressant, monoamine oxidase inhibitor and neuroleptic withdrawal phenomena. <span><span class="ref-journal">Prog Neuropsychopharmacol Biol Psychiatry. </span>1990;<span class="ref-vol">14</span>:137–161.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/1968671" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Prog+Neuropsychopharmacol+Biol+Psychiatry&amp;title=Heterocyclic+antidepressant,+monoamine+oxidase+inhibitor+and+neuroleptic+withdrawal+phenomena&amp;author=SC+Dilsaver&amp;volume=14&amp;publication_year=1990&amp;pages=137-161&amp;pmid=1968671&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b27"><span class="citation">Halle MT, Dilsaver SC. Tranylcypromine withdrawal phenomena. <span><span class="ref-journal">J Psychiatry Neurosci. </span>1993;<span class="ref-vol">18</span>:49–50.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1188476/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/8461282" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Psychiatry+Neurosci&amp;title=Tranylcypromine+withdrawal+phenomena&amp;author=MT+Halle&amp;author=SC+Dilsaver&amp;volume=18&amp;publication_year=1993&amp;pages=49-50&amp;pmid=8461282&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b28"><span class="citation">Dallal A, Chouinard G. Withdrawal and rebound symptoms associated with abrupt discontinuation of venlafaxine [letter] <span><span class="ref-journal">J Clin Psychopharmacol. </span>1998;<span class="ref-vol">18</span>:343–344.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/9690703" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Psychopharmacol&amp;title=Withdrawal+and+rebound+symptoms+associated+with+abrupt+discontinuation+of+venlafaxine+[letter]&amp;author=A+Dallal&amp;author=G+Chouinard&amp;volume=18&amp;publication_year=1998&amp;pages=343-344&amp;pmid=9690703&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b29"><span class="citation">Pollock BG. Discontinuation symptoms and SSRIs [letter with reply] <span><span class="ref-journal">J Clin Psychiatry. </span>1998;<span class="ref-vol">59</span>:535–537.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/9818635" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Psychiatry&amp;title=Discontinuation+symptoms+and+SSRIs+[letter+with+reply]&amp;author=BG+Pollock&amp;volume=59&amp;publication_year=1998&amp;pages=535-537&amp;pmid=9818635&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b30"><span class="citation">Pyke RE. Paroxetine withdrawal syndrome [letter] <span><span class="ref-journal">Am J Psychiatry. </span>1995;<span class="ref-vol">152</span>:149–150.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/7802108" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Am+J+Psychiatry&amp;title=Paroxetine+withdrawal+syndrome+[letter]&amp;author=RE+Pyke&amp;volume=152&amp;publication_year=1995&amp;pages=149-150&amp;pmid=7802108&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b31"><span class="citation">Rosenbaum JF, Fava M, Hoog SL, et al. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. <span><span class="ref-journal">Biol Psychiatry. </span>1998;<span class="ref-vol">44</span>:77–87.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/9646889" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Biol+Psychiatry&amp;title=Selective+serotonin+reuptake+inhibitor+discontinuation+syndrome:+a+randomized+clinical+trial&amp;author=JF+Rosenbaum&amp;author=M+Fava&amp;author=SL+Hoog&amp;author=+et+al&amp;volume=44&amp;publication_year=1998&amp;pages=77-87&amp;pmid=9646889&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b32"><span class="citation">Schatzberg AF. Introduction. Antidepressant discontinuation syndrome: an update on serotonin reuptake inhibitors. <span><span class="ref-journal">J Clin Psychiatry. </span>1997;<span class="ref-vol">58</span>(suppl 7):3–4.</span> <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Psychiatry&amp;title=Introduction.+Antidepressant+discontinuation+syndrome:+an+update+on+serotonin+reuptake+inhibitors&amp;author=AF+Schatzberg&amp;volume=58&amp;issue=suppl+7&amp;publication_year=1997&amp;pages=3-4&amp;pmid=9427870&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b33"><span class="citation">Owens MJ, Morgan WN, Plott SJ, et al. Neurotransmitter receptor and transporter binding profile of anitdepressants and their metabolites. <span><span class="ref-journal">J Pharmacol Exp Ther. </span>1997;<span class="ref-vol">283</span>:1305–1322.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/9400006" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;title=Neurotransmitter+receptor+and+transporter+binding+profile+of+anitdepressants+and+their+metabolites&amp;author=MJ+Owens&amp;author=WN+Morgan&amp;author=SJ+Plott&amp;author=+et+al&amp;volume=283&amp;publication_year=1997&amp;pages=1305-1322&amp;pmid=9400006&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b34"><span class="citation">Rauch SL, O'Sullivan RL, Jenike MA. Open treatment of obsessive-compulsive disorder with venlafaxine: a series of ten cases [letter] <span><span class="ref-journal">J Clin Psychopharmacol. </span>1996;<span class="ref-vol">16</span>:81–84.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/8834427" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Psychopharmacol&amp;title=Open+treatment+of+obsessive-compulsive+disorder+with+venlafaxine:+a+series+of+ten+cases+[letter]&amp;author=SL+Rauch&amp;author=RL+O'Sullivan&amp;author=MA+Jenike&amp;volume=16&amp;publication_year=1996&amp;pages=81-84&amp;pmid=8834427&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b35"><span class="citation">Rosenbaum JF. Separating discontinuation symptoms from relapse [abstract] <span><span class="ref-journal">Eur Neuropsychopharmacol. </span>1999;<span class="ref-vol">9</span>(suppl 5):S188.</span> <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Eur+Neuropsychopharmacol&amp;title=Separating+discontinuation+symptoms+from+relapse+[abstract]&amp;author=JF+Rosenbaum&amp;volume=9&amp;issue=suppl+5&amp;publication_year=1999&amp;pages=S188&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b36"><span class="citation">Boerner RJ, Möller HJ. The importance of new antidepressants in the treatment of anxiety/depressive disorders. <span><span class="ref-journal">Pharmacopsychiatry. </span>1999;<span class="ref-vol">32</span>:119–126.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/10505481" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Pharmacopsychiatry&amp;title=The+importance+of+new+antidepressants+in+the+treatment+of+anxiety/depressive+disorders&amp;author=RJ+Boerner&amp;author=HJ+Möller&amp;volume=32&amp;publication_year=1999&amp;pages=119-126&amp;pmid=10505481&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b37"><span class="citation">Derivan A, Entsuah AR, Kikta D. Venlafaxine: measuring the onset of antidepressant action. <span><span class="ref-journal">Psychopharmacol Bull. </span>1995;<span class="ref-vol">31</span>:439–447.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/7491403" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacol+Bull&amp;title=Venlafaxine:+measuring+the+onset+of+antidepressant+action&amp;author=A+Derivan&amp;author=AR+Entsuah&amp;author=D+Kikta&amp;volume=31&amp;publication_year=1995&amp;pages=439-447&amp;pmid=7491403&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b38"><span class="citation">Muth EA, Moyer JA, Haskins JT, et al. Biochemical, neurophysiological, and behavioral effects of Wy-45, 233 and other identified metabolites of the antidepressant venlafaxine. <span><span class="ref-journal">Drug Dev Res. </span>1991;<span class="ref-vol">23</span>:191–199.</span> <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Drug+Dev+Res&amp;title=Biochemical,+neurophysiological,+and+behavioral+effects+of+Wy-45,+233+and+other+identified+metabolites+of+the+antidepressant+venlafaxine&amp;author=EA+Muth&amp;author=JA+Moyer&amp;author=JT+Haskins&amp;author=+et+al&amp;volume=23&amp;publication_year=1991&amp;pages=191-199&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b39"><span class="citation">Lazowick AL, Levin GM. Potential withdrawal syndrome associated with SSRI discontinuation. <span><span class="ref-journal">Ann Pharmacother. </span>1995;<span class="ref-vol">29</span>:1284–1285.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/8672834" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Ann+Pharmacother&amp;title=Potential+withdrawal+syndrome+associated+with+SSRI+discontinuation&amp;author=AL+Lazowick&amp;author=GM+Levin&amp;volume=29&amp;publication_year=1995&amp;pages=1284-1285&amp;pmid=8672834&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b40"><span class="citation">Effexor XR. (venlafaxine hydrochloride extended release capsules). <span class="ref-title">Physicians' Desk Reference</span>. 54th ed. Montvale, NJ: Medical Economics. 2000 3237–3242. <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar?q=Effexor+XR+.++(venlafaxine+hydrochloride+extended+release+capsules)+.++Physicians'+Desk+Reference+.++54th+ed.+Montvale,+NJ:+Medical+Economics+.++2000+ +3237+–+3242+.+" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b41"><span class="citation">Garner EM, Kelly MW, Thompson DF. Tricyclic antidepressant withdrawal syndrome. <span><span class="ref-journal">Ann Pharmacother. </span>1993;<span class="ref-vol">27</span>:1068–1072.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/8219442" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Ann+Pharmacother&amp;title=Tricyclic+antidepressant+withdrawal+syndrome&amp;author=EM+Garner&amp;author=MW+Kelly&amp;author=DF+Thompson&amp;volume=27&amp;publication_year=1993&amp;pages=1068-1072&amp;pmid=8219442&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li><li id="i1523-5998-003-04-0168-b42"><span class="citation">Wolfe RM. Antidepressant withdrawal reactions. <span><span class="ref-journal">Am Fam Physician. </span>1997;<span class="ref-vol">56</span>:455–462.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/9262526" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Am+Fam+Physician&amp;title=Antidepressant+withdrawal+reactions&amp;author=RM+Wolfe&amp;volume=56&amp;publication_year=1997&amp;pages=455-462&amp;pmid=9262526&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></li></ul></div></div><div aria-hidden="true" aria-live="assertive" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu" style="display: none; width: 200px; top: -100px; left: -100px;"><ul id="ui-ncbiinpagenav-2"><li><a href="https://www.ncbi.nlm.nih.gov/#idm140192431959952title">Abstract</a></li><li><a href="https://www.ncbi.nlm.nih.gov/#s2title">WHEN TO DISCONTINUE ANTIDEPRESSANT THERAPY</a></li><li><a href="https://www.ncbi.nlm.nih.gov/#s3title">RISKS ASSOCIATED WITH DISCONTINUING ANTIDEPRESSANT THERAPY</a></li><li><a href="https://www.ncbi.nlm.nih.gov/#s4title">ANTIDEPRESSANT DISCONTINUATION: RECOMMENDATIONS FOR DOSAGE TAPERING</a></li><li><a href="https://www.ncbi.nlm.nih.gov/#s5title">PREVENTION AND MANAGEMENT OF DISCONTINUATION SYMPTOMS</a></li><li><a href="https://www.ncbi.nlm.nih.gov/#s6title">CONCLUSION</a></li><li><a href="https://www.ncbi.nlm.nih.gov/#idm140192429824800title">Footnotes</a></li><li><a href="https://www.ncbi.nlm.nih.gov/#idm140192438980048title">REFERENCES</a></li></ul></div></div><div class="courtesy-note whole_rhythm small"><hr/>Articles from <span class="acknowledgment-journal-title">Primary Care Companion to The Journal of Clinical Psychiatry</span> are provided here courtesy of <strong>Physicians Postgraduate Press, Inc.</strong></div></div>
</div>
</div>
<div class="four_col col last" id="rightcolumn">
<div class="col6">
</div>
<div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC181183/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC181183/#s3title/pmc/articles/PMC181183/epub/">ePub (beta)</a></li> | <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC181183/pdf/i1523-5998-003-04-0168.pdf">PDF (44K)</a></li> | <li><a aria-expanded="false" aria-haspopup="true" class="citationexporter ctxp" data-citationid="PMC181183" href="https://www.ncbi.nlm.nih.gov/#" role="button">Citation</a></li></ul></div></div><div class="share-buttons" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><h2>Share</h2><ul><li class="facebook"><a aria-expanded="false" aria-haspopup="true" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC181183%2F" role="button" target="_blank"><img alt="Share on Facebook" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626"/>
                             Facebook
                        </a></li><li class="twitter"><a aria-expanded="false" aria-haspopup="true" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC181183%2F&amp;text=Steps%20Following%20Attainment%20of%20Remission%3A%20Discontinuation%20of%20Antidepressant%20Therapy" role="button" target="_blank"><img alt="Share on Twitter" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627"/>
                             Twitter
                        </a></li><li class="gplus"><a aria-expanded="false" aria-haspopup="true" href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC181183%2F" role="button" target="_blank"><img alt="Share on Google Plus" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628"/>
                             Google+
                        </a></li></ul></div>
<div data-accid="PMC181183" data-aid="181183" data-aiid="181183" data-domain="pccj" data-domainid="130" data-iid="5822" data-md5="7eb0a3774a536ce4a1d0a31282c89f20" data-pmid="15014601" id="ajax-portlets">
<div class="portlet pubmed_favoritesad">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Save items</span></h3></div>
<a aria-expanded="false" class="portlet_shutter shutter_closed ui-ncbitoggler" href="https://www.ncbi.nlm.nih.gov/#" name="Shutter" pgsec_name="pmfavad" remembercollapsed="true" role="button" sid="1" style="position: absolute; padding: 0px;" title="Show/hide content" toggles="ui-portlet_content-4"></a>
</div>
<div aria-live="assertive" class="ui-helper-reset"><div aria-hidden="true" class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave" id="ui-portlet_content-4" style="display: none;"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<input id="absid" name="absid" type="hidden" value="181183"/><div class="empty" data-db="pmc" id="pubmed_favoritesad">
<span role="menubar"><div aria-expanded="false" aria-haspopup="true" class="ui-ncbisetswitch ltd-hover" role="menuitem"><a class="jig-ncbisetswitch blind collink ltd-hover ui-ncbisetswitch-hasStar" data-jigconfig="destSelector:'#favUL',starExists:true,createCollectionUrl:'#',manageCollectionsUrl:'/myncbi/collections/'" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC181183/#s3title/myncbi/collections/" id="favList"><span class="star"></span>Add to Favorites</a><a class="ui-ncbisetswitch-button ltd-hover" href="https://www.ncbi.nlm.nih.gov/#" title="View more options"><span class="ui-icon ui-icon-triangle-1-s ui-ncbisetswitch-down">View more options</span></a></div></span><div aria-hidden="true" aria-live="assertive" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu ui-ncbisetswitch-popper" style="display: none; width: 200px; top: -100px; left: -100px;"><ul class="ui-ncbisetswitch-options" id="favUL"></ul><ul class="ui-ncbisetswitch-actions"><li class="ui-ncbisetswitch-actions-create" style="display: block;"><a class="ui-ncbisetswitch-create-collection" href="https://www.ncbi.nlm.nih.gov/#">Create collection...</a></li><li class="ui-ncbisetswitch-actions-manage" style="display: block;"><a class="ui-ncbisetswitch-manage-collections" href="https://www.ncbi.nlm.nih.gov/myncbi/collections/">Manage collections...</a></li></ul></div>
</div>
<div class="colloading">loading</div>
<span id="submenu_AddToCollections"><form method="post"><input class="button_apply" name="addtocollection" type="submit" value="1"/></form></span>
</div></div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div>
<a aria-expanded="true" class="portlet_shutter ui-ncbitoggler-open" href="https://www.ncbi.nlm.nih.gov/#" name="Shutter" pgsec_name="PBooksDiscovery_RA" remembercollapsed="true" role="button" sid="1" style="position: absolute; padding: 0px;" title="Show/hide content" toggles="ui-portlet_content-5"></a>
</div>
<div aria-live="assertive" class="ui-helper-reset"><div aria-hidden="false" class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-5">
<ul>
<li class="brieflinkpopper two_line">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pubmed/30194544" ref="reftype=relart&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button">Other Antidepressants.</a><span class="source">[Handb Exp Pharmacol. 2019]</span><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-6" style="top: -100px; left: -100px; display: none;">
<em class="author" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Schwasinger-Schmidt TE, Macaluso M. </em><em class="cit" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Handb Exp Pharmacol. 2019; 250:325-355. </em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pubmed/28876724" ref="reftype=relart&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button">Treatment of Depression: A Systematic Review</a><span class="source">[ 2004]</span><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-7" style="top: -100px; left: -100px; display: none;">
<em class="author" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Swedish Council on Health Technology Assessment. </em><em class="cit" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">2004 Mar</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pubmed/12832239" ref="reftype=relart&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button">Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up.</a><span class="source">[Am J Psychiatry. 2003]</span><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-8" style="top: -100px; left: -100px; display: none;">
<em class="author" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Altshuler L, Suppes T, Black D, Nolen WA, Keck PE Jr, Frye MA, McElroy S, Kupka R, Grunze H, Walden J, et al. </em><em class="cit" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Am J Psychiatry. 2003 Jul; 160(7):1252-62. </em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pubmed/9219493" ref="reftype=relart&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button">Clinical management of antidepressant discontinuation.</a><span class="source">[J Clin Psychiatry. 1997]</span><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-9" style="top: -100px; left: -100px; display: none;">
<em class="author" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Rosenbaum JF, Zajecka J. </em><em class="cit" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">J Clin Psychiatry. 1997; 58 Suppl 7:37-40. </em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pubmed/29761488" ref="reftype=relart&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button">Psychological therapies for treatment-resistant depression in adults.</a><span class="source">[Cochrane Database Syst Rev. 2018]</span><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-10" style="top: -100px; left: -100px; display: none;">
<em class="author" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Ijaz S, Davies P, Williams CJ, Kessler D, Lewis G, Wiles N. </em><em class="cit" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Cochrane Database Syst Rev. 2018 May 14; 5:CD010558. Epub 2018 May 14.</em>
</div>
</li>
</ul>
<a class="seemore" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=15014601&amp;log%24=relatedreviews&amp;logdbfrom=pmc" ref="reftype=relart&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Reviews&amp;rendering-type=normal">See reviews...</a><a class="seemore" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=15014601&amp;log%24=relatedarticles&amp;logdbfrom=pmc" ref="reftype=relart&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Related%20Records&amp;rendering-type=normal">See all...</a>
</div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Cited by other articles in PMC</span></h3></div>
<a aria-expanded="false" class="portlet_shutter shutter_closed ui-ncbitoggler" href="https://www.ncbi.nlm.nih.gov/#" name="Shutter" pgsec_name="PMCVCitedByPmcArticlesP" remembercollapsed="true" role="button" sid="1" style="position: absolute; padding: 0px;" title="Show/hide content" toggles="ui-portlet_content-11"></a>
</div>
<div aria-live="assertive" class="ui-helper-reset"><div aria-hidden="true" class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave" id="ui-portlet_content-11" style="display: none;">
<ul>
<li class="brieflinkpopper two_line">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166708/" ref="reftype=relart&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button">Relapse prevention in adults with major depressive disorder treated with vilazodone: a randomized, double-blind, placebo-controlled trial</a><span class="source">[International Clinical Psychop...]</span><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-12" style="top: -100px; left: -100px; display: none;">
<em class="author" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Durgam S, Gommoll C, Migliore R, Chen C, Chang CT, Aguirre M, Thase ME. </em><em class="cit" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">International Clinical Psychopharmacology. 2018 Sep 27; 33(6): 304-311</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662806/" ref="reftype=relart&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button">Palpitations and Asthenia Associated with Venlafaxine in a CYP2D6 Poor Metabolizer and CYP2C19 Intermediate Metabolizer</a><span class="source">[Case Reports in Genetics. 2017]</span><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-13" style="top: -100px; left: -100px; display: none;">
<em class="author" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Garcia S, Schuh M, Cheema A, Atwal H, Atwal PS. </em><em class="cit" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Case Reports in Genetics. 2017 Oct 16; 2017: 6236714</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5081583/" ref="reftype=relart&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button">Human amygdala engagement moderated by early life stress exposure is a biobehavioral target for predicting recovery on antidepressants</a><span class="source">[Proceedings of the National Ac...]</span><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-14" style="top: -100px; left: -100px; display: none;">
<em class="author" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Goldstein-Piekarski AN, Korgaonkar MS, Green E, Suppes T, Schatzberg AF, Hastie T, Nemeroff CB, Williams LM. </em><em class="cit" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Proceedings of the National Academy of Sciences of the United States of America. 2016 Oct 10; 113(42): 11955-11960</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5068807/" ref="reftype=relart&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button">Long-term consequences of chronic fluoxetine exposure on the expression of myelination-related genes in the rat hippocampus</a><span class="source">[Translational Psychiatry. 2015]</span><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-15" style="top: -100px; left: -100px; display: none;">
<em class="author" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Kroeze Y, Peeters D, Boulle F, van den Hove DL, van Bokhoven H, Zhou H, Homberg JR. </em><em class="cit" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Translational Psychiatry. 2015 Sep 22; 5(9): e642-</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2778422/" ref="reftype=relart&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button">Predictors of premature discontinuation of treatment in multiple disease states</a><span class="source">[Patient preference and adheren...]</span><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-16" style="top: -100px; left: -100px; display: none;">
<em class="author" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Nantz E, Liu-Seifert H, Skljarevski V. </em><em class="cit" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Patient preference and adherence. 2009 Nov 3; 3: 31-43</em>
</div>
</li>
</ul>
<a class="seemore" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC181183/citedby/" ref="reftype=relart&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|CitedBy&amp;rendering-type=normal">See all...</a>
</div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Links</span></h3></div>
<a aria-expanded="false" class="portlet_shutter shutter_closed ui-ncbitoggler" href="https://www.ncbi.nlm.nih.gov/#" name="Shutter" pgsec_name="PMCVCitedByPmcArticlesP" remembercollapsed="true" role="button" sid="1" style="position: absolute; padding: 0px;" title="Show/hide content" toggles="ui-portlet_content-17"></a>
</div>
<div aria-live="assertive" class="ui-helper-reset"><div aria-hidden="true" class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave" id="ui-portlet_content-17" style="display: none;"><ul>
<li class="brieflinkpopper">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pmc/?Db=medgen&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_medgen&amp;IdsFromResult=181183" ref="reftype=MedGen&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Unknown%20Link%20Name&amp;rendering-type=normal" role="button">MedGen</a><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-18" style="top: -100px; left: -100px; display: none;">MedGen<div class="brieflinkpopdesc">Related information in MedGen</div>
</div>
</li>
<li class="brieflinkpopper">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pubmed/15014601/" ref="reftype=PubMed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|PubMed|Record&amp;rendering-type=normal" role="button">PubMed</a><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-19" style="top: -100px; left: -100px; display: none;">PubMed<div class="brieflinkpopdesc">PubMed citations for these articles</div>
</div>
</li>
<li class="brieflinkpopper">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC181183/#s3title/pmc/?Db=taxonomy&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_taxonomy&amp;IdsFromResult=181183" ref="reftype=Taxonomy&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Taxonomy&amp;rendering-type=normal" role="button">Taxonomy</a><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-20" style="top: -100px; left: -100px; display: none;">Taxonomy<div class="brieflinkpopdesc">Related taxonomy entry</div>
</div>
</li>
</ul></div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Recent Activity</span></h3></div>
<a aria-expanded="true" class="portlet_shutter ui-ncbitoggler-open" href="https://www.ncbi.nlm.nih.gov/#" name="Shutter" pgsec_name="recent_activity" remembercollapsed="true" role="button" sid="1" style="position: absolute; padding: 0px;" title="Show/hide content" toggles="ui-portlet_content-21"></a>
</div>
<div aria-live="assertive" class="ui-helper-reset"><div aria-hidden="false" class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-21"><div class="" id="HTDisplay" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<div class="action">
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC181183/#s3title/javascript:historyDisplayState('ClearHT')">Clear</a><a class="HTOn" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC181183/#s3title/javascript:historyDisplayState('HTOff')">Turn Off</a><a class="HTOff" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC181183/#s3title/javascript:historyDisplayState('HTOn')">Turn On</a>
</div>
<ul id="activity"><li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC181183/#s3title/portal/utils/pageresolver.fcgi?recordid=5d2c960439a66e685911b30e" ref="log$=activity&amp;linkpos=1">Steps Following Attainment of Remission: Discontinuation of Antidepressant Thera...</a><div class="ralinkpop offscreen_noflow">Steps Following Attainment of Remission: Discontinuation of Antidepressant Therapy<div class="brieflinkpopdesc">Primary Care Companion to The Journal of Clinical Psychiatry. 2001; 3(4)168</div>
</div>
<div class="tertiary"></div>
</li></ul>
<p class="HTOn">Your browsing activity is empty.</p>
<p class="HTOff">Activity recording is turned off.</p>
<p class="HTOff" id="turnOn"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC181183/#s3title/javascript:historyDisplayState('HTOn')">Turn recording back on</a></p>
<a class="seemore" href="https://www.ncbi.nlm.nih.gov/sites/myncbi/recentactivity">See more...</a>
</div></div></div>
</div>
<div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p3" name="crb--__p3" rid="__p3" style="position: absolute; visibility: visible; width: 370px; top: 930px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-22"><ul>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b1">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/1417434/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Time to recovery, chronicity, and levels of psychopathology in major depression. A 5-year prospective follow-up of 431 subjects.</a><span class="one_line_source">[Arch Gen Psychiatry.  1992]</span><div class="alt-note">
<div class="authors">Keller MB, Lavori PW, Mueller TI, Endicott J, Coryell W, Hirschfeld RM, Shea T</div>
<div class="citation">Arch Gen Psychiatry. 1992 Oct; 49(10):809-16.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b2">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/10721877/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Delineating the longitudinal structure of depressive illness: beyond clinical subtypes and duration thresholds.</a><span class="one_line_source">[Pharmacopsychiatry.  2000]</span><div class="alt-note">
<div class="authors">Judd LL, Akiskal HS</div>
<div class="citation">Pharmacopsychiatry. 2000 Jan; 33(1):3-7.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p4" name="crb--__p4" rid="__p4" style="position: absolute; visibility: visible; width: 370px; top: 1027px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-23"><ul>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b2">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/10721877/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Delineating the longitudinal structure of depressive illness: beyond clinical subtypes and duration thresholds.</a><span class="one_line_source">[Pharmacopsychiatry.  2000]</span><div class="alt-note">
<div class="authors">Judd LL, Akiskal HS</div>
<div class="citation">Pharmacopsychiatry. 2000 Jan; 33(1):3-7.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b4">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/8803651/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Efficacy of venlafaxine and placebo during long-term treatment of depression: a pooled analysis of relapse rates.</a><span class="one_line_source">[Int Clin Psychopharmacol.  1996]</span><div class="alt-note">
<div class="authors">Entsuah AR, Rudolph RL, Hackett D, Miska S</div>
<div class="citation">Int Clin Psychopharmacol. 1996 Jun; 11(2):137-45.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b7">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/8637947/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Residual symptoms after partial remission: an important outcome in depression.</a><span class="one_line_source">[Psychol Med.  1995]</span><div class="alt-note">
<div class="authors">Paykel ES, Ramana R, Cooper Z, Hayhurst H, Kerr J, Barocka A</div>
<div class="citation">Psychol Med. 1995 Nov; 25(6):1171-80.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b8" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9500681/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Remission and residual symptomatology in major depression.</a><span class="one_line_source">[Psychopathology.  1998]</span><div class="alt-note">
<div class="authors">Paykel ES</div>
<div class="citation">Psychopathology. 1998; 31(1):5-14.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b3" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/10634353/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Clinical guidelines for establishing remission in patients with depression and anxiety.</a><span class="one_line_source">[J Clin Psychiatry.  1999]</span><div class="alt-note">
<div class="authors">Ballenger JC</div>
<div class="citation">J Clin Psychiatry. 1999; 60 Suppl 22():29-34.</div>
</div>
</li>
</ul><a class="seemore" href="https://www.ncbi.nlm.nih.gov/">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p5" name="crb--__p5" rid="__p5" style="position: absolute; visibility: visible; width: 370px; top: 1214px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-24"><ul>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b4">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/8803651/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Efficacy of venlafaxine and placebo during long-term treatment of depression: a pooled analysis of relapse rates.</a><span class="one_line_source">[Int Clin Psychopharmacol.  1996]</span><div class="alt-note">
<div class="authors">Entsuah AR, Rudolph RL, Hackett D, Miska S</div>
<div class="citation">Int Clin Psychopharmacol. 1996 Jun; 11(2):137-45.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b9">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9219488/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Antidepressant discontinuation: a review of the literature.</a><span class="one_line_source">[J Clin Psychiatry.  1997]</span><div class="alt-note">
<div class="authors">Lejoyeux M, Adès J</div>
<div class="citation">J Clin Psychiatry. 1997; 58 Suppl 7():11-5; discussion 16.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p8" name="crb--__p8" rid="__p8" style="position: absolute; visibility: visible; width: 370px; top: 1627px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-25"><ul><li class="two_line" reference_id="i1523-5998-003-04-0168-b3">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/10634353/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Clinical guidelines for establishing remission in patients with depression and anxiety.</a><span class="one_line_source">[J Clin Psychiatry.  1999]</span><div class="alt-note">
<div class="authors">Ballenger JC</div>
<div class="citation">J Clin Psychiatry. 1999; 60 Suppl 22():29-34.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p9" name="crb--__p9" rid="__p9" style="position: absolute; visibility: visible; width: 370px; top: 1999px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-26"><ul>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b3">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/10634353/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Clinical guidelines for establishing remission in patients with depression and anxiety.</a><span class="one_line_source">[J Clin Psychiatry.  1999]</span><div class="alt-note">
<div class="authors">Ballenger JC</div>
<div class="citation">J Clin Psychiatry. 1999; 60 Suppl 22():29-34.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b1">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/1417434/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Time to recovery, chronicity, and levels of psychopathology in major depression. A 5-year prospective follow-up of 431 subjects.</a><span class="one_line_source">[Arch Gen Psychiatry.  1992]</span><div class="alt-note">
<div class="authors">Keller MB, Lavori PW, Mueller TI, Endicott J, Coryell W, Hirschfeld RM, Shea T</div>
<div class="citation">Arch Gen Psychiatry. 1992 Oct; 49(10):809-16.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p10" name="crb--__p10" rid="__p10" style="position: absolute; visibility: visible; width: 370px; top: 2203px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-27"><ul>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b1">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/1417434/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Time to recovery, chronicity, and levels of psychopathology in major depression. A 5-year prospective follow-up of 431 subjects.</a><span class="one_line_source">[Arch Gen Psychiatry.  1992]</span><div class="alt-note">
<div class="authors">Keller MB, Lavori PW, Mueller TI, Endicott J, Coryell W, Hirschfeld RM, Shea T</div>
<div class="citation">Arch Gen Psychiatry. 1992 Oct; 49(10):809-16.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b10">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9755357/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression.</a><span class="one_line_source">[Biol Psychiatry.  1998]</span><div class="alt-note">
<div class="authors">Keller MB, Boland RJ</div>
<div class="citation">Biol Psychiatry. 1998 Sep 1; 44(5):348-60.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p12" name="crb--__p12" rid="__p12" style="position: absolute; visibility: visible; width: 370px; top: 2538px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-28"><ul>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b1">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/1417434/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Time to recovery, chronicity, and levels of psychopathology in major depression. A 5-year prospective follow-up of 431 subjects.</a><span class="one_line_source">[Arch Gen Psychiatry.  1992]</span><div class="alt-note">
<div class="authors">Keller MB, Lavori PW, Mueller TI, Endicott J, Coryell W, Hirschfeld RM, Shea T</div>
<div class="citation">Arch Gen Psychiatry. 1992 Oct; 49(10):809-16.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b4">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/8803651/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Efficacy of venlafaxine and placebo during long-term treatment of depression: a pooled analysis of relapse rates.</a><span class="one_line_source">[Int Clin Psychopharmacol.  1996]</span><div class="alt-note">
<div class="authors">Entsuah AR, Rudolph RL, Hackett D, Miska S</div>
<div class="citation">Int Clin Psychopharmacol. 1996 Jun; 11(2):137-45.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b10">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9755357/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression.</a><span class="one_line_source">[Biol Psychiatry.  1998]</span><div class="alt-note">
<div class="authors">Keller MB, Boland RJ</div>
<div class="citation">Biol Psychiatry. 1998 Sep 1; 44(5):348-60.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b7">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/8637947/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Residual symptoms after partial remission: an important outcome in depression.</a><span class="one_line_source">[Psychol Med.  1995]</span><div class="alt-note">
<div class="authors">Paykel ES, Ramana R, Cooper Z, Hayhurst H, Kerr J, Barocka A</div>
<div class="citation">Psychol Med. 1995 Nov; 25(6):1171-80.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b8">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9500681/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Remission and residual symptomatology in major depression.</a><span class="one_line_source">[Psychopathology.  1998]</span><div class="alt-note">
<div class="authors">Paykel ES</div>
<div class="citation">Psychopathology. 1998; 31(1):5-14.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b2" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/10721877/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Delineating the longitudinal structure of depressive illness: beyond clinical subtypes and duration thresholds.</a><span class="one_line_source">[Pharmacopsychiatry.  2000]</span><div class="alt-note">
<div class="authors">Judd LL, Akiskal HS</div>
<div class="citation">Pharmacopsychiatry. 2000 Jan; 33(1):3-7.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b11" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/3976921/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">NIMH/NIH Consensus Development Conference statement. Mood disorders: pharmacologic prevention of recurrences. Consensus Development Panel.</a><span class="one_line_source">[Am J Psychiatry.  1985]</span><div class="alt-note">
<div class="authors"></div>
<div class="citation">Am J Psychiatry. 1985 Apr; 142(4):469-76.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b12" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6645026/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Predictors of relapse in major depressive disorder.</a><span class="one_line_source">[JAMA.  1983]</span><div class="alt-note">
<div class="authors">Keller MB, Lavori PW, Lewis CE, Klerman GL</div>
<div class="citation">JAMA. 1983 Dec 23-30; 250(24):3299-304.</div>
</div>
</li>
</ul><a class="seemore" href="https://www.ncbi.nlm.nih.gov/">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p13" name="crb--__p13" rid="__p13" style="position: absolute; visibility: visible; width: 370px; top: 2773px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-29"><ul>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b1">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/1417434/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Time to recovery, chronicity, and levels of psychopathology in major depression. A 5-year prospective follow-up of 431 subjects.</a><span class="one_line_source">[Arch Gen Psychiatry.  1992]</span><div class="alt-note">
<div class="authors">Keller MB, Lavori PW, Mueller TI, Endicott J, Coryell W, Hirschfeld RM, Shea T</div>
<div class="citation">Arch Gen Psychiatry. 1992 Oct; 49(10):809-16.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b12">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6645026/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Predictors of relapse in major depressive disorder.</a><span class="one_line_source">[JAMA.  1983]</span><div class="alt-note">
<div class="authors">Keller MB, Lavori PW, Lewis CE, Klerman GL</div>
<div class="citation">JAMA. 1983 Dec 23-30; 250(24):3299-304.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b13" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/10360137/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Recurrence of first-episode geriatric depression after discontinuation of maintenance antidepressants.</a><span class="one_line_source">[Am J Psychiatry.  1999]</span><div class="alt-note">
<div class="authors">Flint AJ, Rifat SL</div>
<div class="citation">Am J Psychiatry. 1999 Jun; 156(6):943-5.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b11" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/3976921/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">NIMH/NIH Consensus Development Conference statement. Mood disorders: pharmacologic prevention of recurrences. Consensus Development Panel.</a><span class="one_line_source">[Am J Psychiatry.  1985]</span><div class="alt-note">
<div class="authors"></div>
<div class="citation">Am J Psychiatry. 1985 Apr; 142(4):469-76.</div>
</div>
</li>
</ul><a class="seemore" href="https://www.ncbi.nlm.nih.gov/">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p16" name="crb--__p16" rid="__p16" style="position: absolute; visibility: visible; width: 370px; top: 3192px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-30"><ul>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b15">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6324897/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Antidepressant withdrawal phenomena.</a><span class="one_line_source">[Biol Psychiatry.  1984]</span><div class="alt-note">
<div class="authors">Dilsaver SC, Greden JF</div>
<div class="citation">Biol Psychiatry. 1984 Feb; 19(2):237-56.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b16" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9818638/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Discontinuation of antidepressant therapy: emerging complications and their relevance.</a><span class="one_line_source">[J Clin Psychiatry.  1998]</span><div class="alt-note">
<div class="authors">Thompson C</div>
<div class="citation">J Clin Psychiatry. 1998 Oct; 59(10):541-8.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b17" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9269249/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review.</a><span class="one_line_source">[J Clin Psychiatry.  1997]</span><div class="alt-note">
<div class="authors">Zajecka J, Tracy KA, Mitchell S</div>
<div class="citation">J Clin Psychiatry. 1997 Jul; 58(7):291-7.</div>
</div>
</li>
</ul><a class="seemore" href="https://www.ncbi.nlm.nih.gov/">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p17" name="crb--__p17" rid="__p17" style="position: absolute; visibility: visible; width: 370px; top: 3751px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-31"><ul><li class="two_line" reference_id="i1523-5998-003-04-0168-b18">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9219493/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Clinical management of antidepressant discontinuation.</a><span class="one_line_source">[J Clin Psychiatry.  1997]</span><div class="alt-note">
<div class="authors">Rosenbaum JF, Zajecka J</div>
<div class="citation">J Clin Psychiatry. 1997; 58 Suppl 7():37-40.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p18" name="crb--__p18" rid="__p18" style="position: absolute; visibility: visible; width: 370px; top: 3827px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-32"><ul>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b19">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9552943/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Antidepressant discontinuation reactions.</a><span class="one_line_source">[BMJ.  1998]</span><div class="alt-note">
<div class="authors">Haddad P, Lejoyeux M, Young A</div>
<div class="citation">BMJ. 1998 Apr 11; 316(7138):1105-6.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b20">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/8109661/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Withdrawal reaction after sertraline discontinuation.</a><span class="one_line_source">[Am J Psychiatry.  1994]</span><div class="alt-note">
<div class="authors">Louie AK, Lannon RA, Ajari LJ</div>
<div class="citation">Am J Psychiatry. 1994 Mar; 151(3):450-1.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b16">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9818638/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Discontinuation of antidepressant therapy: emerging complications and their relevance.</a><span class="one_line_source">[J Clin Psychiatry.  1998]</span><div class="alt-note">
<div class="authors">Thompson C</div>
<div class="citation">J Clin Psychiatry. 1998 Oct; 59(10):541-8.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b9" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9219488/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Antidepressant discontinuation: a review of the literature.</a><span class="one_line_source">[J Clin Psychiatry.  1997]</span><div class="alt-note">
<div class="authors">Lejoyeux M, Adès J</div>
<div class="citation">J Clin Psychiatry. 1997; 58 Suppl 7():11-5; discussion 16.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b24" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/2923004/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Antidepressant withdrawal syndromes: phenomenology and pathophysiology.</a><span class="one_line_source">[Acta Psychiatr Scand.  1989]</span><div class="alt-note">
<div class="authors">Dilsaver SC</div>
<div class="citation">Acta Psychiatr Scand. 1989 Feb; 79(2):113-7.</div>
</div>
</li>
</ul><a class="seemore" href="https://www.ncbi.nlm.nih.gov/">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p19" name="crb--__p19" rid="__p19" style="position: absolute; visibility: visible; width: 370px; top: 4012px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-33"><ul>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b15">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6324897/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Antidepressant withdrawal phenomena.</a><span class="one_line_source">[Biol Psychiatry.  1984]</span><div class="alt-note">
<div class="authors">Dilsaver SC, Greden JF</div>
<div class="citation">Biol Psychiatry. 1984 Feb; 19(2):237-56.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b23">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9219490/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Possible biological mechanisms of the serotonin reuptake inhibitor discontinuation syndrome. Discontinuation Consensus Panel.</a><span class="one_line_source">[J Clin Psychiatry.  1997]</span><div class="alt-note">
<div class="authors">Schatzberg AF, Haddad P, Kaplan EM, Lejoyeux M, Rosenbaum JF, Young AH, Zajecka J</div>
<div class="citation">J Clin Psychiatry. 1997; 58 Suppl 7():23-7.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p21" name="crb--__p21" rid="__p21" style="position: absolute; visibility: visible; width: 370px; top: 4226px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-34"><ul>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b15">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6324897/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Antidepressant withdrawal phenomena.</a><span class="one_line_source">[Biol Psychiatry.  1984]</span><div class="alt-note">
<div class="authors">Dilsaver SC, Greden JF</div>
<div class="citation">Biol Psychiatry. 1984 Feb; 19(2):237-56.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b24">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/2923004/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Antidepressant withdrawal syndromes: phenomenology and pathophysiology.</a><span class="one_line_source">[Acta Psychiatr Scand.  1989]</span><div class="alt-note">
<div class="authors">Dilsaver SC</div>
<div class="citation">Acta Psychiatr Scand. 1989 Feb; 79(2):113-7.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b23">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9219490/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Possible biological mechanisms of the serotonin reuptake inhibitor discontinuation syndrome. Discontinuation Consensus Panel.</a><span class="one_line_source">[J Clin Psychiatry.  1997]</span><div class="alt-note">
<div class="authors">Schatzberg AF, Haddad P, Kaplan EM, Lejoyeux M, Rosenbaum JF, Young AH, Zajecka J</div>
<div class="citation">J Clin Psychiatry. 1997; 58 Suppl 7():23-7.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p22" name="crb--__p22" rid="__p22" style="position: absolute; visibility: visible; width: 370px; top: 4457px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-35"><ul>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b25">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/7912078/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Withdrawal phenomena associated with antidepressant and antipsychotic agents.</a><span class="one_line_source">[Drug Saf.  1994]</span><div class="alt-note">
<div class="authors">Dilsaver SC</div>
<div class="citation">Drug Saf. 1994 Feb; 10(2):103-14.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b26">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/1968671/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Heterocyclic antidepressant, monoamine oxidase inhibitor and neuroleptic withdrawal phenomena.</a><span class="one_line_source">[Prog Neuropsychopharmacol Biol Psychiatry.  1990]</span><div class="alt-note">
<div class="authors">Dilsaver SC</div>
<div class="citation">Prog Neuropsychopharmacol Biol Psychiatry. 1990; 14(2):137-61.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b27">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/8461282/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Tranylcypromine withdrawal phenomena.</a><span class="one_line_source">[J Psychiatry Neurosci.  1993]</span><div class="alt-note">
<div class="authors">Halle MT, Dilsaver SC</div>
<div class="citation">J Psychiatry Neurosci. 1993 Jan; 18(1):49-50.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p23" name="crb--__p23" rid="__p23" style="position: absolute; visibility: visible; width: 370px; top: 5062px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-36"><ul><li class="two_line" reference_id="i1523-5998-003-04-0168-b17">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9269249/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review.</a><span class="one_line_source">[J Clin Psychiatry.  1997]</span><div class="alt-note">
<div class="authors">Zajecka J, Tracy KA, Mitchell S</div>
<div class="citation">J Clin Psychiatry. 1997 Jul; 58(7):291-7.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p24" name="crb--__p24" rid="__p24" style="position: absolute; visibility: visible; width: 370px; top: 5222px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-37"><ul>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b15">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6324897/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Antidepressant withdrawal phenomena.</a><span class="one_line_source">[Biol Psychiatry.  1984]</span><div class="alt-note">
<div class="authors">Dilsaver SC, Greden JF</div>
<div class="citation">Biol Psychiatry. 1984 Feb; 19(2):237-56.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b17">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9269249/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review.</a><span class="one_line_source">[J Clin Psychiatry.  1997]</span><div class="alt-note">
<div class="authors">Zajecka J, Tracy KA, Mitchell S</div>
<div class="citation">J Clin Psychiatry. 1997 Jul; 58(7):291-7.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b18" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9219493/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Clinical management of antidepressant discontinuation.</a><span class="one_line_source">[J Clin Psychiatry.  1997]</span><div class="alt-note">
<div class="authors">Rosenbaum JF, Zajecka J</div>
<div class="citation">J Clin Psychiatry. 1997; 58 Suppl 7():37-40.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b23" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9219490/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Possible biological mechanisms of the serotonin reuptake inhibitor discontinuation syndrome. Discontinuation Consensus Panel.</a><span class="one_line_source">[J Clin Psychiatry.  1997]</span><div class="alt-note">
<div class="authors">Schatzberg AF, Haddad P, Kaplan EM, Lejoyeux M, Rosenbaum JF, Young AH, Zajecka J</div>
<div class="citation">J Clin Psychiatry. 1997; 58 Suppl 7():23-7.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b28" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9690703/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Withdrawal and rebound symptoms associated with abrupt discontinuation of venlafaxine.</a><span class="one_line_source">[J Clin Psychopharmacol.  1998]</span><div class="alt-note">
<div class="authors">Dallal A, Chouinard G</div>
<div class="citation">J Clin Psychopharmacol. 1998 Aug; 18(4):343-4.</div>
</div>
</li>
</ul><a class="seemore" href="https://www.ncbi.nlm.nih.gov/">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p25" name="crb--__p25" rid="__p25" style="position: absolute; visibility: visible; width: 370px; top: 5361px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-38"><ul>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b29">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9818635/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Discontinuation symptoms and SSRIs.</a><span class="one_line_source">[J Clin Psychiatry.  1998]</span><div class="alt-note">
<div class="authors">Pollock BG</div>
<div class="citation">J Clin Psychiatry. 1998 Oct; 59(10):535-7.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b31">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9646889/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.</a><span class="one_line_source">[Biol Psychiatry.  1998]</span><div class="alt-note">
<div class="authors">Rosenbaum JF, Fava M, Hoog SL, Ascroft RC, Krebs WB</div>
<div class="citation">Biol Psychiatry. 1998 Jul 15; 44(2):77-87.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p26" name="crb--__p26" rid="__p26" style="position: absolute; visibility: visible; width: 370px; top: 5632px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-39"><ul>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b23">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9219490/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Possible biological mechanisms of the serotonin reuptake inhibitor discontinuation syndrome. Discontinuation Consensus Panel.</a><span class="one_line_source">[J Clin Psychiatry.  1997]</span><div class="alt-note">
<div class="authors">Schatzberg AF, Haddad P, Kaplan EM, Lejoyeux M, Rosenbaum JF, Young AH, Zajecka J</div>
<div class="citation">J Clin Psychiatry. 1997; 58 Suppl 7():23-7.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b30">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/7802108/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Paroxetine withdrawal syndrome.</a><span class="one_line_source">[Am J Psychiatry.  1995]</span><div class="alt-note">
<div class="authors">Pyke RE</div>
<div class="citation">Am J Psychiatry. 1995 Jan; 152(1):149-50.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p27" name="crb--__p27" rid="__p27" style="position: absolute; visibility: visible; width: 370px; top: 5838px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-40"><ul><li class="two_line" reference_id="i1523-5998-003-04-0168-b33">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9400006/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites.</a><span class="one_line_source">[J Pharmacol Exp Ther.  1997]</span><div class="alt-note">
<div class="authors">Owens MJ, Morgan WN, Plott SJ, Nemeroff CB</div>
<div class="citation">J Pharmacol Exp Ther. 1997 Dec; 283(3):1305-22.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p28" name="crb--__p28" rid="__p28" style="position: absolute; visibility: visible; width: 370px; top: 5977px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-41"><ul>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b34">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/8834427/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Open treatment of obsessive-compulsive disorder with venlafaxine: a series of ten cases.</a><span class="one_line_source">[J Clin Psychopharmacol.  1996]</span><div class="alt-note">
<div class="authors">Rauch SL, O'Sullivan RL, Jenike MA</div>
<div class="citation">J Clin Psychopharmacol. 1996 Feb; 16(1):81-4.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b28">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9690703/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Withdrawal and rebound symptoms associated with abrupt discontinuation of venlafaxine.</a><span class="one_line_source">[J Clin Psychopharmacol.  1998]</span><div class="alt-note">
<div class="authors">Dallal A, Chouinard G</div>
<div class="citation">J Clin Psychopharmacol. 1998 Aug; 18(4):343-4.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p30" name="crb--__p30" rid="__p30" style="position: absolute; visibility: visible; width: 370px; top: 6360px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-42"><ul><li class="two_line" reference_id="i1523-5998-003-04-0168-b18">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9219493/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Clinical management of antidepressant discontinuation.</a><span class="one_line_source">[J Clin Psychiatry.  1997]</span><div class="alt-note">
<div class="authors">Rosenbaum JF, Zajecka J</div>
<div class="citation">J Clin Psychiatry. 1997; 58 Suppl 7():37-40.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p31" name="crb--__p31" rid="__p31" style="position: absolute; visibility: visible; width: 370px; top: 6501px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-43"><ul>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b36">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/10505481/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> The importance of new antidepressants in the treatment of anxiety/depressive disorders.</a><span class="one_line_source">[Pharmacopsychiatry.  1999]</span><div class="alt-note">
<div class="authors">Boerner RJ, Möller HJ</div>
<div class="citation">Pharmacopsychiatry. 1999 Jul; 32(4):119-26.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b37">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/7491403/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Venlafaxine: measuring the onset of antidepressant action.</a><span class="one_line_source">[Psychopharmacol Bull.  1995]</span><div class="alt-note">
<div class="authors">Derivan A, Entsuah AR, Kikta D</div>
<div class="citation">Psychopharmacol Bull. 1995; 31(2):439-47.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p32" name="crb--__p32" rid="__p32" style="position: absolute; visibility: visible; width: 370px; top: 6785px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-44"><ul>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b15">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6324897/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Antidepressant withdrawal phenomena.</a><span class="one_line_source">[Biol Psychiatry.  1984]</span><div class="alt-note">
<div class="authors">Dilsaver SC, Greden JF</div>
<div class="citation">Biol Psychiatry. 1984 Feb; 19(2):237-56.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b18">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9219493/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Clinical management of antidepressant discontinuation.</a><span class="one_line_source">[J Clin Psychiatry.  1997]</span><div class="alt-note">
<div class="authors">Rosenbaum JF, Zajecka J</div>
<div class="citation">J Clin Psychiatry. 1997; 58 Suppl 7():37-40.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p33" name="crb--__p33" rid="__p33" style="position: absolute; visibility: visible; width: 370px; top: 6947px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-45"><ul>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b39">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/8672834/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Potential withdrawal syndrome associated with SSRI discontinuation.</a><span class="one_line_source">[Ann Pharmacother.  1995]</span><div class="alt-note">
<div class="authors">Lazowick AL, Levin GM</div>
<div class="citation">Ann Pharmacother. 1995 Dec; 29(12):1284-85.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b18">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9219493/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Clinical management of antidepressant discontinuation.</a><span class="one_line_source">[J Clin Psychiatry.  1997]</span><div class="alt-note">
<div class="authors">Rosenbaum JF, Zajecka J</div>
<div class="citation">J Clin Psychiatry. 1997; 58 Suppl 7():37-40.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b25">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/7912078/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Withdrawal phenomena associated with antidepressant and antipsychotic agents.</a><span class="one_line_source">[Drug Saf.  1994]</span><div class="alt-note">
<div class="authors">Dilsaver SC</div>
<div class="citation">Drug Saf. 1994 Feb; 10(2):103-14.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p34" name="crb--__p34" rid="__p34" style="position: absolute; visibility: visible; width: 370px; top: 7816px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-46"><ul>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b28">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9690703/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Withdrawal and rebound symptoms associated with abrupt discontinuation of venlafaxine.</a><span class="one_line_source">[J Clin Psychopharmacol.  1998]</span><div class="alt-note">
<div class="authors">Dallal A, Chouinard G</div>
<div class="citation">J Clin Psychopharmacol. 1998 Aug; 18(4):343-4.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b19">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9552943/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Antidepressant discontinuation reactions.</a><span class="one_line_source">[BMJ.  1998]</span><div class="alt-note">
<div class="authors">Haddad P, Lejoyeux M, Young A</div>
<div class="citation">BMJ. 1998 Apr 11; 316(7138):1105-6.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b18">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9219493/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Clinical management of antidepressant discontinuation.</a><span class="one_line_source">[J Clin Psychiatry.  1997]</span><div class="alt-note">
<div class="authors">Rosenbaum JF, Zajecka J</div>
<div class="citation">J Clin Psychiatry. 1997; 58 Suppl 7():37-40.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p35" name="crb--__p35" rid="__p35" style="position: absolute; visibility: visible; width: 370px; top: 8062px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-47"><ul><li class="two_line" reference_id="i1523-5998-003-04-0168-b16">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9818638/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Discontinuation of antidepressant therapy: emerging complications and their relevance.</a><span class="one_line_source">[J Clin Psychiatry.  1998]</span><div class="alt-note">
<div class="authors">Thompson C</div>
<div class="citation">J Clin Psychiatry. 1998 Oct; 59(10):541-8.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p36" name="crb--__p36" rid="__p36" style="position: absolute; visibility: visible; width: 370px; top: 8432px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-48"><ul><li class="two_line" reference_id="i1523-5998-003-04-0168-b41">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/8219442/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Tricyclic antidepressant withdrawal syndrome.</a><span class="one_line_source">[Ann Pharmacother.  1993]</span><div class="alt-note">
<div class="authors">Garner EM, Kelly MW, Thompson DF</div>
<div class="citation">Ann Pharmacother. 1993 Sep; 27(9):1068-72.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p37" name="crb--__p37" rid="__p37" style="position: absolute; visibility: visible; width: 370px; top: 8550px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-49"><ul>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b18">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9219493/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Clinical management of antidepressant discontinuation.</a><span class="one_line_source">[J Clin Psychiatry.  1997]</span><div class="alt-note">
<div class="authors">Rosenbaum JF, Zajecka J</div>
<div class="citation">J Clin Psychiatry. 1997; 58 Suppl 7():37-40.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b41">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/8219442/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Tricyclic antidepressant withdrawal syndrome.</a><span class="one_line_source">[Ann Pharmacother.  1993]</span><div class="alt-note">
<div class="authors">Garner EM, Kelly MW, Thompson DF</div>
<div class="citation">Ann Pharmacother. 1993 Sep; 27(9):1068-72.</div>
</div>
</li>
<li class="two_line" reference_id="i1523-5998-003-04-0168-b42">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9262526/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Antidepressant withdrawal reactions.</a><span class="one_line_source">[Am Fam Physician.  1997]</span><div class="alt-note">
<div class="authors">Wolfe RM</div>
<div class="citation">Am Fam Physician. 1997 Aug; 56(2):455-62.</div>
</div>
</li>
</ul></div>
</div>
</div>
</div>
<div class="col7">
</div>
</div>
</div>
<div class="col8">
</div>
<div class="col9">
</div>
<script src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
<div id="body-link-poppers"><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-i1523-5998-003-04-0168-b1" style="display: none; width: 30em; top: -100px; left: -100px;">Time to recovery, chronicity, and levels of psychopathology in major depression. A 5-year prospective follow-up of 431 subjects.<div class="authors">Keller MB, Lavori PW, Mueller TI, Endicott J, Coryell W, Hirschfeld RM, Shea T</div><div class="citation">Arch Gen Psychiatry. 1992 Oct; 49(10):809-16.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/1417434/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b1">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-i1523-5998-003-04-0168-b2" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Delineating the longitudinal structure of depressive illness: beyond clinical subtypes and duration thresholds.<div class="authors">Judd LL, Akiskal HS</div><div class="citation">Pharmacopsychiatry. 2000 Jan; 33(1):3-7.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/10721877/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b2">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-i1523-5998-003-04-0168-b4" style="display: none; width: 30em; top: -100px; left: -100px;">Efficacy of venlafaxine and placebo during long-term treatment of depression: a pooled analysis of relapse rates.<div class="authors">Entsuah AR, Rudolph RL, Hackett D, Miska S</div><div class="citation">Int Clin Psychopharmacol. 1996 Jun; 11(2):137-45.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/8803651/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b4">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-i1523-5998-003-04-0168-b7" style="display: none; width: 30em; top: -100px; left: -100px;">Residual symptoms after partial remission: an important outcome in depression.<div class="authors">Paykel ES, Ramana R, Cooper Z, Hayhurst H, Kerr J, Barocka A</div><div class="citation">Psychol Med. 1995 Nov; 25(6):1171-80.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/8637947/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b7">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-i1523-5998-003-04-0168-b8" style="display: none; width: 30em; top: -100px; left: -100px;">Remission and residual symptomatology in major depression.<div class="authors">Paykel ES</div><div class="citation">Psychopathology. 1998; 31(1):5-14.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/9500681/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b8">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-i1523-5998-003-04-0168-b3" style="display: none; width: 30em; top: -100px; left: -100px;">Clinical guidelines for establishing remission in patients with depression and anxiety.<div class="authors">Ballenger JC</div><div class="citation">J Clin Psychiatry. 1999; 60 Suppl 22():29-34.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/10634353/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b3">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-i1523-5998-003-04-0168-b9" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Antidepressant discontinuation: a review of the literature.<div class="authors">Lejoyeux M, Adès J</div><div class="citation">J Clin Psychiatry. 1997; 58 Suppl 7():11-5; discussion 16.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/9219488/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b9">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-i1523-5998-003-04-0168-b10" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression.<div class="authors">Keller MB, Boland RJ</div><div class="citation">Biol Psychiatry. 1998 Sep 1; 44(5):348-60.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/9755357/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b10">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-i1523-5998-003-04-0168-b11" style="display: none; width: 30em; top: -100px; left: -100px;">NIMH/NIH Consensus Development Conference statement. Mood disorders: pharmacologic prevention of recurrences. Consensus Development Panel.<div class="authors"></div><div class="citation">Am J Psychiatry. 1985 Apr; 142(4):469-76.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/3976921/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b11">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-i1523-5998-003-04-0168-b12" style="display: none; width: 30em; top: -100px; left: -100px;">Predictors of relapse in major depressive disorder.<div class="authors">Keller MB, Lavori PW, Lewis CE, Klerman GL</div><div class="citation">JAMA. 1983 Dec 23-30; 250(24):3299-304.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6645026/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b12">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-i1523-5998-003-04-0168-b13" style="display: none; width: 30em; top: -100px; left: -100px;">Recurrence of first-episode geriatric depression after discontinuation of maintenance antidepressants.<div class="authors">Flint AJ, Rifat SL</div><div class="citation">Am J Psychiatry. 1999 Jun; 156(6):943-5.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/10360137/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b13">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-i1523-5998-003-04-0168-b14" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="citation">Lejoyeux M, Ades J, Mourad I, et al. Antidepressant withdrawal syndrome: recognition, prevention and management. <span><span class="ref-journal">CNS Drugs. </span>1996;<span class="ref-vol">5</span>:278–292.</span> <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=CNS+Drugs&amp;title=Antidepressant+withdrawal+syndrome:+recognition,+prevention+and+management&amp;author=M+Lejoyeux&amp;author=J+Ades&amp;author=I+Mourad&amp;author=+et+al&amp;volume=5&amp;publication_year=1996&amp;pages=278-292&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b14">Ref list</a>]</div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-i1523-5998-003-04-0168-b15" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Antidepressant withdrawal phenomena.<div class="authors">Dilsaver SC, Greden JF</div><div class="citation">Biol Psychiatry. 1984 Feb; 19(2):237-56.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6324897/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b15">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-i1523-5998-003-04-0168-b16" style="display: none; width: 30em; top: -100px; left: -100px;">Discontinuation of antidepressant therapy: emerging complications and their relevance.<div class="authors">Thompson C</div><div class="citation">J Clin Psychiatry. 1998 Oct; 59(10):541-8.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/9818638/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b16">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-i1523-5998-003-04-0168-b17" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review.<div class="authors">Zajecka J, Tracy KA, Mitchell S</div><div class="citation">J Clin Psychiatry. 1997 Jul; 58(7):291-7.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/9269249/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b17">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-i1523-5998-003-04-0168-b18" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Clinical management of antidepressant discontinuation.<div class="authors">Rosenbaum JF, Zajecka J</div><div class="citation">J Clin Psychiatry. 1997; 58 Suppl 7():37-40.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/9219493/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b18">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-i1523-5998-003-04-0168-b19" style="display: none; width: 30em; top: -100px; left: -100px;">Antidepressant discontinuation reactions.<div class="authors">Haddad P, Lejoyeux M, Young A</div><div class="citation">BMJ. 1998 Apr 11; 316(7138):1105-6.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/9552943/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b19">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-i1523-5998-003-04-0168-b20" style="display: none; width: 30em; top: -100px; left: -100px;">Withdrawal reaction after sertraline discontinuation.<div class="authors">Louie AK, Lannon RA, Ajari LJ</div><div class="citation">Am J Psychiatry. 1994 Mar; 151(3):450-1.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/8109661/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b20">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-i1523-5998-003-04-0168-b24" style="display: none; width: 30em; top: -100px; left: -100px;">Antidepressant withdrawal syndromes: phenomenology and pathophysiology.<div class="authors">Dilsaver SC</div><div class="citation">Acta Psychiatr Scand. 1989 Feb; 79(2):113-7.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/2923004/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b24">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-i1523-5998-003-04-0168-b22" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="citation">Khan A. Three cases of adverse symptoms occurring after the discontinuation of venlafaxine [letter] <span><span class="ref-journal">Psychiatr Ann. </span>1997;<span class="ref-vol">27</span>:259.</span> <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Psychiatr+Ann&amp;title=Three+cases+of+adverse+symptoms+occurring+after+the+discontinuation+of+venlafaxine+[letter]&amp;author=A+Khan&amp;volume=27&amp;publication_year=1997&amp;pages=259&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b22">Ref list</a>]</div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-i1523-5998-003-04-0168-b23" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Possible biological mechanisms of the serotonin reuptake inhibitor discontinuation syndrome. Discontinuation Consensus Panel.<div class="authors">Schatzberg AF, Haddad P, Kaplan EM, Lejoyeux M, Rosenbaum JF, Young AH, Zajecka J</div><div class="citation">J Clin Psychiatry. 1997; 58 Suppl 7():23-7.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/9219490/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b23">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-i1523-5998-003-04-0168-b25" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Withdrawal phenomena associated with antidepressant and antipsychotic agents.<div class="authors">Dilsaver SC</div><div class="citation">Drug Saf. 1994 Feb; 10(2):103-14.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/7912078/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b25">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-i1523-5998-003-04-0168-b26" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Heterocyclic antidepressant, monoamine oxidase inhibitor and neuroleptic withdrawal phenomena.<div class="authors">Dilsaver SC</div><div class="citation">Prog Neuropsychopharmacol Biol Psychiatry. 1990; 14(2):137-61.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/1968671/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b26">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-i1523-5998-003-04-0168-b27" style="display: none; width: 30em; top: -100px; left: -100px;">Tranylcypromine withdrawal phenomena.<div class="authors">Halle MT, Dilsaver SC</div><div class="citation">J Psychiatry Neurosci. 1993 Jan; 18(1):49-50.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/8461282/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b27">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-i1523-5998-003-04-0168-b28" style="display: none; width: 30em; top: -100px; left: -100px;">Withdrawal and rebound symptoms associated with abrupt discontinuation of venlafaxine.<div class="authors">Dallal A, Chouinard G</div><div class="citation">J Clin Psychopharmacol. 1998 Aug; 18(4):343-4.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/9690703/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b28">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-i1523-5998-003-04-0168-b29" style="display: none; width: 30em; top: -100px; left: -100px;">Discontinuation symptoms and SSRIs.<div class="authors">Pollock BG</div><div class="citation">J Clin Psychiatry. 1998 Oct; 59(10):535-7.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/9818635/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b29">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-i1523-5998-003-04-0168-b31" style="display: none; width: 30em; top: -100px; left: -100px;">Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.<div class="authors">Rosenbaum JF, Fava M, Hoog SL, Ascroft RC, Krebs WB</div><div class="citation">Biol Psychiatry. 1998 Jul 15; 44(2):77-87.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/9646889/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b31">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-i1523-5998-003-04-0168-b30" style="display: none; width: 30em; top: -100px; left: -100px;">Paroxetine withdrawal syndrome.<div class="authors">Pyke RE</div><div class="citation">Am J Psychiatry. 1995 Jan; 152(1):149-50.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/7802108/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b30">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-i1523-5998-003-04-0168-b33" style="display: none; width: 30em; top: -100px; left: -100px;">Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites.<div class="authors">Owens MJ, Morgan WN, Plott SJ, Nemeroff CB</div><div class="citation">J Pharmacol Exp Ther. 1997 Dec; 283(3):1305-22.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/9400006/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b33">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-i1523-5998-003-04-0168-b34" style="display: none; width: 30em; top: -100px; left: -100px;">Open treatment of obsessive-compulsive disorder with venlafaxine: a series of ten cases.<div class="authors">Rauch SL, O'Sullivan RL, Jenike MA</div><div class="citation">J Clin Psychopharmacol. 1996 Feb; 16(1):81-4.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/8834427/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b34">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-i1523-5998-003-04-0168-b35" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="citation">Rosenbaum JF. Separating discontinuation symptoms from relapse [abstract] <span><span class="ref-journal">Eur Neuropsychopharmacol. </span>1999;<span class="ref-vol">9</span>(suppl 5):S188.</span> <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Eur+Neuropsychopharmacol&amp;title=Separating+discontinuation+symptoms+from+relapse+[abstract]&amp;author=JF+Rosenbaum&amp;volume=9&amp;issue=suppl+5&amp;publication_year=1999&amp;pages=S188&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b35">Ref list</a>]</div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-i1523-5998-003-04-0168-b32" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="citation">Schatzberg AF. Introduction. Antidepressant discontinuation syndrome: an update on serotonin reuptake inhibitors. <span><span class="ref-journal">J Clin Psychiatry. </span>1997;<span class="ref-vol">58</span>(suppl 7):3–4.</span> <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Psychiatry&amp;title=Introduction.+Antidepressant+discontinuation+syndrome:+an+update+on+serotonin+reuptake+inhibitors&amp;author=AF+Schatzberg&amp;volume=58&amp;issue=suppl+7&amp;publication_year=1997&amp;pages=3-4&amp;pmid=9427870&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b32">Ref list</a>]</div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-i1523-5998-003-04-0168-b36" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> The importance of new antidepressants in the treatment of anxiety/depressive disorders.<div class="authors">Boerner RJ, Möller HJ</div><div class="citation">Pharmacopsychiatry. 1999 Jul; 32(4):119-26.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/10505481/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b36">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-i1523-5998-003-04-0168-b37" style="display: none; width: 30em; top: -100px; left: -100px;">Venlafaxine: measuring the onset of antidepressant action.<div class="authors">Derivan A, Entsuah AR, Kikta D</div><div class="citation">Psychopharmacol Bull. 1995; 31(2):439-47.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/7491403/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b37">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-i1523-5998-003-04-0168-b38" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="citation">Muth EA, Moyer JA, Haskins JT, et al. Biochemical, neurophysiological, and behavioral effects of Wy-45, 233 and other identified metabolites of the antidepressant venlafaxine. <span><span class="ref-journal">Drug Dev Res. </span>1991;<span class="ref-vol">23</span>:191–199.</span> <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Drug+Dev+Res&amp;title=Biochemical,+neurophysiological,+and+behavioral+effects+of+Wy-45,+233+and+other+identified+metabolites+of+the+antidepressant+venlafaxine&amp;author=EA+Muth&amp;author=JA+Moyer&amp;author=JT+Haskins&amp;author=+et+al&amp;volume=23&amp;publication_year=1991&amp;pages=191-199&amp;" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b38">Ref list</a>]</div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-i1523-5998-003-04-0168-b39" style="display: none; width: 30em; top: -100px; left: -100px;">Potential withdrawal syndrome associated with SSRI discontinuation.<div class="authors">Lazowick AL, Levin GM</div><div class="citation">Ann Pharmacother. 1995 Dec; 29(12):1284-85.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/8672834/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b39">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-i1523-5998-003-04-0168-b40" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="citation">Effexor XR. (venlafaxine hydrochloride extended release capsules). <span class="ref-title">Physicians' Desk Reference</span>. 54th ed. Montvale, NJ: Medical Economics. 2000 3237–3242. <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar?q=Effexor+XR+.++(venlafaxine+hydrochloride+extended+release+capsules)+.++Physicians'+Desk+Reference+.++54th+ed.+Montvale,+NJ:+Medical+Economics+.++2000+ +3237+–+3242+.+" ref="reftype=other&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b40">Ref list</a>]</div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-i1523-5998-003-04-0168-b41" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Tricyclic antidepressant withdrawal syndrome.<div class="authors">Garner EM, Kelly MW, Thompson DF</div><div class="citation">Ann Pharmacother. 1993 Sep; 27(9):1068-72.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/8219442/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b41">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-i1523-5998-003-04-0168-b42" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Antidepressant withdrawal reactions.<div class="authors">Wolfe RM</div><div class="citation">Am Fam Physician. 1997 Aug; 56(2):455-62.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/9262526/" ref="reftype=pubmed&amp;article-id=181183&amp;issue-id=5822&amp;journal-id=130&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#i1523-5998-003-04-0168-b42">Ref list</a>]</p></div></div>
</div>
<div class="bottom">
<div id="NCBIFooter_dynamic">
<a class="help_desk" href="https://www.ncbi.nlm.nih.gov/" id="help-desk-link" target="_blank">Support Center</a>
<a class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-07-15T11:04:36-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal105&amp;ncbi_phid=CE8C26AAD2C9195100000000036701D6&amp;ncbi_session=CE8C26AAD2C96041_0871SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC181183%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" id="help-desk-link" target="_blank">Support Center</a>
</div>
<div class="footer" id="footer">
<div class="subfooter"> </div><script src="https://www.ncbi.nlm.nih.gov/portal/portal3rc.fcgi/static/js/preloaderWidget.js" type="text/javascript"> </script>
<div class="offscreen_noflow" id="external-disclaimer">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>
<div class="contact_info" id="ncbifooter">
<div id="footer-contents-right">
<div id="nlm_thumb_logo">
<a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
</div>
<div id="nih_thumb_logo">
<a href="https://www.nih.gov" title="NIH">NIH</a>
</div>
<div id="hhs_thumb_logo">
<a href="https://www.hhs.gov" title="DHHS">DHHS</a>
</div>
<div id="usagov_thumb_logo">
<a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
</div>
</div>
<div id="footer-contents-left">
<p class="address vcard">
<span class="url">
<a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
<span class="adr">
<span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
<span class="region">MD</span>, <span class="postal-code">20894</span>
<span class="country-name">USA</span>
</span>
</p>
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC181183/#s3title/home/about/policies.shtml">Policies and Guidelines</a> | <a href="https://www.ncbi.nlm.nih.gov/home/about/contact.shtml">Contact</a>
</div>
</div>
<script src="https://www.ncbi.nlm.nih.gov/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1" type="text/javascript"> </script>
<script src="https://www.ncbi.nlm.nih.gov/portal/portal3rc.fcgi/static/js/hfjs2.js" type="text/javascript"> </script>
</div>
</div>
</div>
</div>
</div>
<div aria-live="assertive" class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" style="display: none; top: 63.5938px; left: 651.688px; width: 670px; z-index: 1001;"><ul aria-activedescendant="term" class="ui-ncbiautocomplete-options" role="listbox"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" href="https://www.ncbi.nlm.nih.gov/#" style="display: block;">Turn off</a></div></div><div aria-hidden="true" aria-live="assertive" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; top: -100px; left: -100px;">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
<span class="PAFAppResources"></span>
<noscript><img alt="statistics" src="https://www.ncbi.nlm.nih.gov/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=pccj&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC181183/&amp;ncbi_app=pmc"/></noscript>
<script snapshot="pmc" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" type="text/javascript"></script>
<div aria-describedby="epubDialog" aria-labelledby="ui-id-1" class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" role="dialog" style="display: none;" tabindex="-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span class="ui-dialog-title" id="ui-id-1">Making articles easier to read in PMC</span><button class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close" type="button"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div class="ui-dialog-content ui-widget-content" id="epubDialog" style="display: block;"> <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p> <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p> <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button class="ui-state-default ui-corner-all" id="cancelEpub">Cancel</button><button class="ui-state-default ui-corner-all" id="downloadEpub" style="float: left">Download article</button></div> </div></div></body></html>